Coding experts Alicia and Laureen from CCO review the new 2025 ICD-10-CM code changes.
View Webinar Recording
JB64.Y Other specified maternal diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 coding note This category includes conditions which complicate the pregnant state, are aggravated by the pregnancy or are a main reason for obstetric care but no specific category exists in this chapter.
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Associated with - multiple selections are allowed [select] 2A00 Primary neoplasms of brain – 2A00.0 Gliomas of brain – 2A00.1 Embryonal tumours of brain – 2A00.2 Tumours of neuroepithelial tissue of brain – 2A00.3 Central neurocytoma of brain – 2A00.4 Astroblastoma of the brain – 2A00.5 Primary neoplasm of brain of unknown or unspecified type –– 2A00.00 Glioblastoma of brain –– 2A00.0Y Other specified gliomas of brain –– 2A00.0Z Gliomas of brain, unspecified –– 2A00.10 Medulloblastoma of brain –– 2A00.11 Central primitive neuroectodermal tumour –– 2A00.1Y Other specified embryonal tumours of brain –– 2A00.1Z Embryonal tumours of brain, unspecified –– 2A00.20 Tumours of the pineal gland or pineal region –– 2A00.21 Mixed neuronal-glial tumours –– 2A00.22 Choroid plexus tumours –– 2A00.2Y Other specified tumours of neuroepithelial tissue of brain –– 2A00.2Z Tumours of neuroepithelial tissue of brain, unspecified 2A01 Primary neoplasms of meninges – 2A01.0 Meningiomas – 2A01.1 Mesenchymal tumours of meninges – 2A01.2 Primary neoplasm of meninges of unknown or unspecified type –– 2A01.00 Primary malignant meningioma –– 2A01.0Y Other specified meningiomas –– 2A01.0Z Meningiomas, unspecified 2A02 Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system – 2A02.0 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system – 2A02.1 Tumours of cranial or paraspinal nerves – 2A02.2 Primary neoplasm of spinal cord of unknown or unspecified type – 2A02.3 Benign neoplasm of cranial nerves – 2A02.4 Benign neoplasm of spinal cord –– 2A02.00 Glioblastoma of spinal cord, cranial nerves or other parts of central nervous system –– 2A02.0Y Other specified gliomas of spinal cord, cranial nerves or other parts of the central nervous system –– 2A02.0Z Gliomas of spinal cord, cranial nerves or other parts of the central nervous system, unspecified –– 2A02.10 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves –– 2A02.11 Paraspinal neuroblastoma –– 2A02.12 Malignant neoplasm of the optic nerve –– 2A02.1Y Other specified tumours of cranial or paraspinal nerves –– 2A02.1Z Tumours of cranial or paraspinal nerves, unspecified 2A0Z Other and unspecified neoplasms of brain or central nervous system – 2A20 Non mast cell myeloproliferative neoplasms –– 2A20.0 Chronic myelogenous leukaemia, BCR-ABL1-positive –– 2A20.1 Chronic neutrophilic leukaemia –– 2A20.2 Primary myelofibrosis –– 2A20.3 Chronic eosinophilic leukaemia, not elsewhere classified –– 2A20.4 Polycythaemia vera –– 2A20.5 Non mast cell myeloproliferative neoplasm, unclassifiable –– 2A20.Y Other specified non mast cell myeloproliferative neoplasms –– 2A20.Z Non mast cell myeloproliferative neoplasms, unspecified ––– 2A20.00 Chronic myelogenous leukaemia with blast crisis ––– 2A20.01 Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive ––– 2A20.02 Chronic myelogenous leukaemia, t(9:22)(q34; q11) ––– 2A20.03 Naegeli-type monocytic leukaemia ––– 2A20.0Y Other specified chronic myelogenous leukaemia, BCR-ABL1-positive ––– 2A20.0Z Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified – 2A21 Mastocytosis –– 2A21.0 Systemic mastocytosis –– 2A21.1 Cutaneous mastocytosis –– 2A21.2 Mast cell sarcoma –– 2A21.3 Extracutaneous mastocytoma –– 2A21.Y Other specified mastocytosis –– 2A21.Z Mastocytosis, unspecified ––– 2A21.00 Mast cell leukaemia ––– 2A21.0Y Other specified systemic mastocytosis ––– 2A21.0Z Systemic mastocytosis, unspecified ––– 2A21.10 Urticaria pigmentosa ––– 2A21.1Y Other specified cutaneous mastocytosis ––– 2A21.1Z Cutaneous mastocytosis, unspecified – 2A22 Other and unspecified myeloproliferative neoplasms – 2A30 Refractory anaemia – 2A31 Refractory neutropaenia – 2A32 Refractory thrombocytopenia – 2A33 Refractory anaemia with ring sideroblasts – 2A34 Refractory cytopenia with multi-lineage dysplasia – 2A35 Refractory anaemia with excess of blasts – 2A36 Myelodysplastic syndrome with isolated del(5q) – 2A37 Myelodysplastic syndrome, unclassifiable – 2A38 Refractory cytopenia of childhood – 2A3Y Other specified myelodysplastic syndromes – 2A3Z Myelodysplastic syndromes, unspecified – 2A40 Chronic myelomonocytic leukaemia – 2A41 Atypical chronic myeloid leukaemia, BCR-ABL1-negative – 2A42 Juvenile myelomonocytic leukaemia –– 2A42.0 Juvenile myelomonocytic leukaemia in complete remission –– 2A42.Y Other specified juvenile myelomonocytic leukaemia –– 2A42.Z Juvenile myelomonocytic leukaemia, unspecified – 2A43 Refractory anaemia with ring sideroblasts associated with marked thrombocytosis – 2A44 Myeloproliferative and myelodysplastic disease, unclassifiable – 2A4Y Other specified myelodysplastic and myeloproliferative neoplasms – 2A4Z Myelodysplastic and myeloproliferative neoplasms, unspecified – 2A50 Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement – 2A51 Myeloid neoplasm associated with PDGFRB rearrangement – 2A52 Myeloid or lymphoid neoplasms with FGFR1 abnormalities – 2A5Z Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified 2A60 Acute myeloid leukaemias and related precursor neoplasms – 2A60.0 Acute myeloid leukaemia with recurrent genetic abnormalities – 2A60.1 Acute myeloid leukaemia with myelodysplasia-related changes – 2A60.2 Therapy-related myeloid neoplasms – 2A60.3 Acute myeloid leukaemia, not elsewhere classified by criteria of other types – 2A60.4 Myeloid proliferation associated with Down syndrome – 2A60.5 Blastic plasmacytoid dendritic cell neoplasm – 2A60.Y Other specified acute myeloid leukaemias and related precursor neoplasms – 2A60.Z Acute myeloid leukaemias and related precursor neoplasms, unspecified –– 2A60.20 Therapy related acute myeloid leukaemia or myelodysplastic syndrome –– 2A60.2Y Other specified therapy-related myeloid neoplasms –– 2A60.2Z Therapy-related myeloid neoplasms, unspecified –– 2A60.30 Acute myeloid leukaemia with minimal differentiation –– 2A60.31 Acute myeloid leukaemia without maturation –– 2A60.32 Acute myeloid leukaemia with maturation –– 2A60.33 Acute myelomonocytic leukaemia –– 2A60.34 Acute monoblastic or monocytic leukaemia –– 2A60.35 Acute erythroid leukaemia –– 2A60.36 Acute megakaryoblastic leukaemia –– 2A60.37 Acute basophilic leukaemia –– 2A60.38 Acute panmyelosis with myelofibrosis –– 2A60.39 Myeloid sarcoma –– 2A60.3Y Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types –– 2A60.3Z Acute myeloid leukaemia, unspecified –– 2A60.40 Transient abnormal myelopoiesis –– 2A60.41 Myeloid leukaemia associated with Down syndrome –– 2A60.4Y Other specified myeloid proliferation associated with Down syndrome –– 2A60.4Z Myeloid proliferation associated with Down syndrome, unspecified 2A61 Acute leukaemias of ambiguous lineage – 2A70 Precursor B-lymphoblastic neoplasms –– 2A70.0 B lymphoblastic leukaemia or lymphoma, not elsewhere classified –– 2A70.1 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 –– 2A70.Y Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities – 2A71 Precursor T-lymphoblastic neoplasms – 2A7Z Precursor lymphoid neoplasms, unspecified – 2A80 Follicular lymphoma –– 2A80.0 Follicular lymphoma grade 1 –– 2A80.1 Follicular lymphoma grade 2 –– 2A80.2 Follicular lymphoma grade 3 –– 2A80.3 Primary cutaneous follicle centre lymphoma –– 2A80.4 Paediatric type follicular lymphoma –– 2A80.5 Follicular lymphoma in situ –– 2A80.6 Follicular lymphoma of small intestine –– 2A80.Y Other specified follicular lymphoma –– 2A80.Z Follicular lymphoma, unspecified – 2A81 Diffuse large B-cell lymphomas –– 2A81.0 Primary mediastinal large B-cell lymphoma –– 2A81.1 Intravascular large B-cell lymphoma –– 2A81.2 Plasmablastic lymphoma –– 2A81.3 Lymphomatoid granulomatosis –– 2A81.4 T-cell/histiocyte rich large B-cell lymphoma –– 2A81.5 Primary diffuse large B-cell lymphoma of central nervous system –– 2A81.6 Epstein-Barr Virus-positive diffuse large B-cell lymphoma of the elderly –– 2A81.7 Diffuse large B-cell lymphoma associated with chronic inflammation –– 2A81.8 ALK-positive large B-cell lymphoma –– 2A81.9 Primary effusion lymphoma –– 2A81.A Primary cutaneous diffuse large B-cell lymphoma, leg type –– 2A81.Y Other specified diffuse large B-cell lymphomas –– 2A81.Z Diffuse large B-cell lymphoma, not otherwise specified – 2A82 Mature B-cell neoplasm with leukaemic behaviour –– 2A82.0 Chronic lymphocytic leukaemia or small lymphocytic lymphoma –– 2A82.1 B-cell prolymphocytic leukaemia –– 2A82.2 Hairy-cell leukaemia –– 2A82.3 Splenic B-cell lymphoma or leukaemia, unclassifiable –– 2A82.Y Other specified mature B-cell neoplasm with leukaemic behaviour –– 2A82.Z Mature B-cell neoplasm with leukaemic behaviour, unspecified ––– 2A82.00 Chronic lymphocytic leukaemia of B-cell type ––– 2A82.0Y Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma ––– 2A82.0Z Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified ––– 2A82.10 B-cell prolymphocytic leukaemia in complete remission ––– 2A82.1Y Other specified b-cell prolymphocytic leukaemia ––– 2A82.1Z B-cell prolymphocytic leukaemia, unspecified – 2A83 Plasma cell neoplasms –– 2A83.0 Monoclonal gammopathy of undetermined significance –– 2A83.1 Plasma cell myeloma –– 2A83.2 Solitary plasmacytoma –– 2A83.3 Extraosseous plasmacytoma –– 2A83.4 Plasma cell leukaemia –– 2A83.5 Monoclonal immunoglobulin deposition disease –– 2A83.Y Other specified multiple myeloma and plasma cell neoplasms –– 2A83.Z Plasma cell neoplasm, unspecified ––– 2A83.50 Heavy chain deposition disease ––– 2A83.51 Light and heavy chain deposition disease ––– 2A83.52 Light chain deposition disease – 2A84 Heavy chain diseases or malignant immunoproliferative diseases –– 2A84.0 Alpha heavy chain disease –– 2A84.1 Gamma heavy chain disease –– 2A84.2 Mu heavy chain disease –– 2A84.Y Other specified malignant immunoproliferative diseases –– 2A84.Z Heavy chain diseases, unspecified – 2A85 Other specified mature B-cell neoplasms or lymphoma –– 2A85.0 Nodal marginal zone lymphoma –– 2A85.1 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach –– 2A85.2 Extranodal marginal zone B-cell lymphoma, primary site skin –– 2A85.3 Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin –– 2A85.4 Lymphoplasmacytic lymphoma –– 2A85.5 Mantle cell lymphoma –– 2A85.6 Burkitt lymphoma including Burkitt leukaemia –– 2A85.Y Further specified mature B-cell neoplasms or lymphoma – 2A86 B-cell lymphoma, mixed features –– 2A86.0 Malignant lymphoma of B cell type, not elsewhere classified –– 2A86.1 B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma –– 2A86.2 B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma –– 2A86.Y Other specified B-cell lymphoma, mixed features –– 2A86.Z B-cell lymphoma, mixed features, unspecified – 2A8Z Mature B-cell neoplasms, unspecified – 2A90 Mature T-cell lymphoma, specified types, nodal or systemic –– 2A90.0 T-cell prolymphocytic leukaemia –– 2A90.1 T-cell large granular lymphocytic leukaemia –– 2A90.2 Chronic lymphoproliferative disorders of NK-cells –– 2A90.3 Aggressive NK cell leukaemia –– 2A90.4 Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood –– 2A90.5 Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated –– 2A90.6 Extranodal NK/T-cell lymphoma, nasal type –– 2A90.7 Enteropathy associated T-cell lymphoma –– 2A90.8 Hepatosplenic T-cell lymphoma –– 2A90.9 Angioimmunoblastic T-cell lymphoma –– 2A90.A Anaplastic large cell lymphoma, ALK-positive –– 2A90.B Anaplastic large cell lymphoma, ALK-negative –– 2A90.C Peripheral T-cell lymphoma, not otherwise specified –– 2B00 Subcutaneous panniculitis-like T-cell lymphoma –– 2B01 Mycosis fungoides –– 2B02 Sézary syndrome –– 2B03 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders ––– 2B03.0 Primary cutaneous CD30-positive anaplastic large cell lymphoma ––– 2B03.1 Lymphomatoid papulosis –– 2B0Y Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders –– 2B0Z Primary cutaneous T-cell lymphoma of undetermined or unspecified type – 2B2Y Other specified mature T-cell or NK-cell neoplasms – 2B2Z Mature T-cell or NK-cell neoplasms, unspecified 2B30 Hodgkin lymphoma – 2B30.0 Nodular lymphocyte predominant Hodgkin lymphoma – 2B30.1 Classical Hodgkin lymphoma – 2B30.Z Hodgkin lymphoma, unspecified –– 2B30.10 Nodular sclerosis classical Hodgkin lymphoma –– 2B30.11 Lymphocyte-rich classical Hodgkin lymphoma –– 2B30.12 Mixed cellularity classical Hodgkin lymphoma –– 2B30.13 Lymphocyte depleted classical Hodgkin lymphoma –– 2B30.1Z Classical Hodgkin lymphoma, unspecified 2B31 Histiocytic or dendritic cell neoplasms – 2B31.0 Juvenile xanthogranuloma – 2B31.1 Histiocytic sarcoma – 2B31.2 Langerhans cell histiocytosis – 2B31.3 Langerhans cell sarcoma – 2B31.4 Interdigitating dendritic cell sarcoma – 2B31.5 Follicular dendritic cell sarcoma – 2B31.6 Indeterminate cell histiocytosis – 2B31.7 Fibroblastic reticular cell tumour – 2B31.Y Other specified histiocytic or dendritic cell neoplasms – 2B31.Z Histiocytic or dendritic cell neoplasms, unspecified –– 2B31.20 Langerhans cell histiocytosis involving the skin –– 2B31.2Y Other specified Langerhans cell histiocytosis –– 2B31.2Z Langerhans cell histiocytosis, unspecified 2B32 Immunodeficiency-associated lymphoproliferative disorders – 2B32.0 Post-transplant lymphoproliferative disorder, early lesion – 2B32.1 Reactive plasmacytic hyperplasia – 2B32.2 Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like – 2B32.3 Polymorphic post-transplant lymphoproliferative disorder – 2B32.Y Other specified immunodeficiency-associated lymphoproliferative disorders – 2B32.Z Immunodeficiency-associated lymphoproliferative disorders, unspecified 2B33 Malignant haematopoietic neoplasms without further specification – 2B33.0 Acute leukaemia, not elsewhere classified – 2B33.1 Myeloid leukaemia – 2B33.2 Chronic myeloid leukaemia, not elsewhere classified – 2B33.3 Lymphoid leukaemia, not elsewhere classified – 2B33.4 Leukaemia, unspecified – 2B33.5 Malignant lymphoma, not elsewhere classified – 2B33.Y Other malignant haematopoietic neoplasms without further specification 2B3Z Neoplasms of haematopoietic or lymphoid tissues, unspecified –– 2B50 Chondrosarcoma, primary site ––– 2B50.0 Chondrosarcoma of bone or articular cartilage of limbs ––– 2B50.1 Chondrosarcoma of bone or articular cartilage of pelvis ––– 2B50.2 Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle ––– 2B50.Y Chondrosarcoma of bone or articular cartilage of other specified sites ––– 2B50.Z Chondrosarcoma of bone or articular cartilage of unspecified sites –– 2B51 Osteosarcoma, primary site ––– 2B51.0 Osteosarcoma of bone or articular cartilage of jaw ––– 2B51.1 Osteosarcoma of bone or articular cartilage of limbs ––– 2B51.2 Osteosarcoma of bone or articular cartilage of pelvis ––– 2B51.Y Osteosarcoma of bone and articular cartilage of other specified sites ––– 2B51.Z Osteosarcoma of bone and articular cartilage of unspecified sites –– 2B52 Ewing sarcoma, primary site ––– 2B52.0 Ewing sarcoma of bone or articular cartilage of limbs ––– 2B52.1 Ewing sarcoma of bone or articular cartilage of pelvis ––– 2B52.2 Ewing sarcoma of bone or articular cartilage of ribs ––– 2B52.3 Ewing sarcoma of soft tissue ––– 2B52.Y Ewing sarcoma of bone and articular cartilage of other specified sites ––– 2B52.Z Ewing sarcoma of bone and articular cartilage of unspecified sites –– 2B53 Fibroblastic or myofibroblastic tumour, primary site ––– 2B53.0 Myxofibrosarcoma, primary site ––– 2B53.1 Fibroblastic or myofibroblastic tumour of skin ––– 2B53.Y Other specified fibroblastic or myofibroblastic tumour, primary site ––– 2B53.Z Fibroblastic or myofibroblastic tumour, primary site, unspecified –– 2B54 Unclassified pleomorphic sarcoma, primary site ––– 2B54.0 Unclassified pleomorphic sarcoma of skin ––– 2B54.1 Unclassified pleomorphic sarcoma of retroperitoneum or peritoneum ––– 2B54.Y Unclassified pleomorphic sarcoma, primary site, other specified site ––– 2B54.Z Unclassified pleomorphic sarcoma, primary site, unspecified site –– 2B55 Rhabdomyosarcoma, primary site ––– 2B55.0 Rhabdomyosarcoma of the oral cavity or pharynx ––– 2B55.1 Rhabdomyosarcoma of respiratory or intrathoracic organs ––– 2B55.2 Rhabdomyosarcoma of male genital organs ––– 2B55.Y Rhabdomyosarcoma, other specified primary site ––– 2B55.Z Rhabdomyosarcoma, unspecified primary site –– 2B56 Angiosarcoma, primary site ––– 2B56.0 Angiosarcoma of heart ––– 2B56.1 Angiosarcoma of skin ––– 2B56.2 Angiosarcoma of breast ––– 2B56.3 Angiosarcoma of liver ––– 2B56.Y Angiosarcoma, other specified primary site ––– 2B56.Z Angiosarcoma, unspecified primary site –– 2B57 Kaposi sarcoma, primary site ––– 2B57.0 Kaposi sarcoma of lung ––– 2B57.1 Kaposi sarcoma of skin ––– 2B57.2 Kaposi sarcoma of gastrointestinal sites ––– 2B57.Y Kaposi sarcoma of other specified primary sites ––– 2B57.Z Kaposi sarcoma of unspecified primary site –– 2B58 Leiomyosarcoma, primary site ––– 2B58.0 Leiomyosarcoma of retroperitoneum or peritoneum ––– 2B58.1 Leiomyosarcoma of uterus ––– 2B58.2 Leiomyosarcoma of stomach ––– 2B58.Y Leiomyosarcoma, other specified primary site ––– 2B58.Z Leiomyosarcoma, unspecified primary site –– 2B59 Liposarcoma, primary site ––– 2B59.0 Liposarcoma of soft tissue of limb ––– 2B59.1 Liposarcoma of retroperitoneum or peritoneum ––– 2B59.2 Liposarcoma of male genital organs ––– 2B59.Y Liposarcoma, other specified primary site ––– 2B59.Z Liposarcoma, unspecified primary site –– 2B5A Synovial sarcoma, primary site ––– 2B5A.0 Synovial sarcoma of soft tissues of limb ––– 2B5A.1 Synovial sarcoma of respiratory or intra-thoracic organs ––– 2B5A.Y Synovial sarcoma, other specified primary site ––– 2B5A.Z Synovial sarcoma, unspecified primary site –– 2B5B Gastrointestinal stromal tumour, primary site ––– 2B5B.0 Gastrointestinal stromal tumour of stomach ––– 2B5B.1 Gastrointestinal stromal tumour of small intestine ––– 2B5B.Y Gastrointestinal stromal tumour of other gastrointestinal sites ––– 2B5B.Z Gastrointestinal stromal tumour of unspecified gastrointestinal sites –– 2B5C Endometrial stromal sarcoma, primary site –– 2B5D Malignant mixed epithelial mesenchymal tumour, primary site ––– 2B5D.0 Malignant mixed epithelial mesenchymal tumour of ovary ––– 2B5D.1 Malignant mixed epithelial and mesenchymal tumour of corpus uteri ––– 2B5D.Y Malignant mixed epithelial mesenchymal tumour, other specified primary site ––– 2B5D.Z Malignant mixed epithelial mesenchymal tumour, unspecified primary site –– 2B5E Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site –– 2B5F Sarcoma, not elsewhere classified, primary site ––– 2B5F.0 Sarcoma, not elsewhere classified of uterus ––– 2B5F.1 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum ––– 2B5F.2 Sarcoma, not elsewhere classified of other specified sites ––– 2B5F.3 Sarcoma, not elsewhere classified, primary site unknown –––– 2B5F.10 Myosarcomas of omentum –––– 2B5F.1Y Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum –––– 2B5F.1Z Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified –– 2B5G Myosarcoma of uterus, part not specified –– 2B5H Well differentiated lipomatous tumour, primary site –– 2B5J Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites –– 2B5K Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites –– 2B5Y Other specified malignant mesenchymal neoplasms –– 2B5Z Malignant mesenchymal neoplasm of unspecified type –– 2B60 Malignant neoplasms of lip ––– 2B60.0 Basal cell carcinoma of lip ––– 2B60.1 Squamous cell carcinoma of lip ––– 2B60.Y Other specified malignant neoplasms of lip ––– 2B60.Z Malignant neoplasms of lip, unspecified –– 2B61 Malignant neoplasms of base of tongue ––– 2B61.0 Squamous cell carcinoma of the base of the tongue ––– 2B61.Y Other specified malignant neoplasms of base of tongue ––– 2B61.Z Malignant neoplasms of base of tongue, unspecified –– 2B62 Malignant neoplasms of other or unspecified parts of tongue ––– 2B62.0 Squamous cell carcinoma of other or unspecified parts of tongue ––– 2B62.1 Malignant neoplasms of lingual tonsil ––– 2B62.Y Other specified malignant neoplasms of other and unspecified parts of tongue ––– 2B62.Z Malignant neoplasms of other or unspecified parts of tongue, unspecified –––– 2B62.10 Squamous cell carcinoma of lingual tonsil –––– 2B62.1Z Malignant neoplasms of lingual tonsil, unspecified –– 2B63 Malignant neoplasms of gum ––– 2B63.0 Squamous cell carcinoma of gum ––– 2B63.Y Other specified malignant neoplasm of gum ––– 2B63.Z Malignant neoplasms of gum, unspecified –– 2B64 Malignant neoplasms of floor of mouth ––– 2B64.0 Squamous cell carcinoma of floor of mouth ––– 2B64.Y Other specified malignant neoplasm of floor of mouth ––– 2B64.Z Malignant neoplasms of floor of mouth, unspecified –– 2B65 Malignant neoplasms of palate ––– 2B65.0 Adenocarcinoma of palate ––– 2B65.1 Squamous cell carcinoma of palate ––– 2B65.Y Other specified malignant neoplasm of palate ––– 2B65.Z Malignant neoplasms of palate, unspecified –– 2B66 Malignant neoplasms of other or unspecified parts of mouth ––– 2B66.0 Squamous cell carcinoma of other or unspecified parts of mouth ––– 2B66.Y Other specified malignant neoplasms of other and unspecified parts of mouth ––– 2B66.Z Malignant neoplasms of other or unspecified parts of mouth, unspecified –– 2B67 Malignant neoplasms of parotid gland ––– 2B67.0 Adenocarcinoma of parotid gland ––– 2B67.1 Squamous cell carcinoma of parotid gland ––– 2B67.Y Other specified malignant neoplasms of parotid gland ––– 2B67.Z Malignant neoplasms of parotid gland, unspecified –– 2B68 Malignant neoplasms of submandibular or sublingual glands ––– 2B68.0 Adenocarcinoma of submandibular or sublingual glands ––– 2B68.1 Squamous cell carcinoma of submandibular or sublingual glands ––– 2B68.2 Other specified malignant neoplasms of submandibular or sublingual glands ––– 2B68.Z Malignant neoplasms of submandibular or sublingual glands, unspecified –– 2B69 Malignant neoplasms of tonsil ––– 2B69.0 Squamous cell carcinoma of tonsil ––– 2B69.1 Other specified malignant neoplasms of tonsil ––– 2B69.Z Malignant neoplasms of tonsil, unspecified –– 2B6A Malignant neoplasms of oropharynx ––– 2B6A.0 Squamous cell carcinoma of oropharynx ––– 2B6A.Y Other specified malignant neoplasms of oropharynx ––– 2B6A.Z Malignant neoplasms of oropharynx, unspecified –– 2B6B Malignant neoplasms of nasopharynx ––– 2B6B.0 Squamous cell carcinoma of nasopharynx ––– 2B6B.1 Malignant epithelial neoplasms of nasopharynx, unspecified type ––– 2B6B.2 Malignant neoplasms of pharyngeal tonsil ––– 2B6B.Y Other specified malignant neoplasms of nasopharynx ––– 2B6B.Z Malignant neoplasms of nasopharynx, unspecified –––– 2B6B.20 Squamous cell carcinoma of pharyngeal tonsil –––– 2B6B.21 Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil –––– 2B6B.2Y Other specified malignant neoplasms of pharyngeal tonsil –––– 2B6B.2Z Malignant neoplasm of pharyngeal tonsil without mention of type –– 2B6C Malignant neoplasms of piriform sinus ––– 2B6C.0 Squamous cell carcinoma of piriform sinus ––– 2B6C.Y Other specified malignant neoplasms of piriform sinus ––– 2B6C.Z Malignant neoplasms of piriform sinus, unspecified –– 2B6D Malignant neoplasms of hypopharynx ––– 2B6D.0 Squamous cell carcinoma of hypopharynx and variants ––– 2B6D.Y Other specified malignant neoplasms of hypopharynx ––– 2B6D.Z Malignant neoplasms of hypopharynx, unspecified –– 2B6E Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.0 Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Y Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Z Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified –– 2B6Y Other specified malignant neoplasms of lip, oral cavity or pharynx –– 2B70 Malignant neoplasms of oesophagus ––– 2B70.0 Adenocarcinoma of oesophagus ––– 2B70.1 Squamous cell carcinoma of oesophagus ––– 2B70.Y Other specified malignant neoplasms of oesophagus ––– 2B70.Z Malignant neoplasms of oesophagus, unspecified –––– 2B70.00 Barrett adenocarcinoma –––– 2B70.0Y Other specified adenocarcinoma of oesophagus –––– 2B70.0Z Adenocarcinoma of oesophagus, unspecified –– 2B71 Malignant neoplasms of oesophagogastric junction ––– 2B71.0 Adenocarcinoma of oesophagogastric junction ––– 2B71.Y Other specified malignant neoplasm of oesophagogastric junction ––– 2B71.Z Malignant neoplasms of oesophagogastric junction, unspecified –– 2B72 Malignant neoplasms of stomach ––– 2B72.0 Adenocarcinoma of stomach ––– 2B72.1 Malignant neuroendocrine neoplasm of stomach ––– 2B72.Y Other specified malignant neoplasms of stomach ––– 2B72.Z Malignant neoplasms of stomach, unspecified ––– 2B80 Malignant neoplasms of small intestine –––– 2B80.0 Malignant neoplasms of duodenum –––– 2B80.1 Malignant neoplasms of jejunum or ileum –––– 2B80.2 Malignant neoplasms of small intestine, site unspecified –––– 2B80.Y Other specified malignant neoplasms of small intestine –––– 2B80.Z Malignant neoplasms of small intestine, unspecified ––––– 2B80.00 Adenocarcinoma of duodenum ––––– 2B80.01 Neuroendocrine neoplasm of duodenum ––––– 2B80.0Y Other specified malignant neoplasms of the duodenum ––––– 2B80.0Z Malignant neoplasms of duodenum, unspecified ––––– 2B80.10 Adenocarcinoma of jejunum or ileum ––––– 2B80.11 Neuroendocrine neoplasms of jejunum or ileum ––––– 2B80.1Y Other specified malignant neoplasms of jejunum or ileum ––––– 2B80.1Z Malignant neoplasms of jejunum or ileum, unspecified ––––– 2B80.20 Adenocarcinoma of small intestine, site unspecified ––––– 2B80.21 Neuroendocrine neoplasms of small intestine, site unspecified ––––– 2B80.2Y Other specified malignant neoplasms of small intestine, site unspecified ––– 2B81 Malignant neoplasms of appendix –––– 2B81.0 Adenocarcinoma of appendix –––– 2B81.2 Neuroendocrine neoplasms of appendix –––– 2B81.Y Other specified malignant neoplasms of appendix –––– 2B81.Z Malignant neoplasms of appendix, unspecified ––––– 2B81.00 Mucinous adenocarcinoma of appendix –––– 2B90 Malignant neoplasms of colon ––––– 2B90.0 Malignant neoplasm of ascending colon and right flexure of colon ––––– 2B90.1 Malignant neoplasm of descending colon and splenic flexure of colon ––––– 2B90.2 Malignant neoplasm of transverse colon ––––– 2B90.3 Malignant neoplasm of sigmoid colon ––––– 2B90.Y Other specified malignant neoplasms of colon ––––– 2B90.Z Malignant neoplasms of colon, unspecified –––––– 2B90.00 Adenocarcinoma of ascending colon or right flexure of colon –––––– 2B90.0Y Other specified malignant neoplasm of ascending colon and right flexure of colon –––––– 2B90.0Z Malignant neoplasm of ascending colon and right flexure of colon, unspecified –––––– 2B90.10 Adenocarcinoma of descending colon or splenic flexure of colon –––––– 2B90.1Y Other specified malignant neoplasm of descending colon and splenic flexure of colon –––––– 2B90.1Z Malignant neoplasm of descending colon and splenic flexure of colon, unspecified –––––– 2B90.20 Adenocarcinoma of transverse colon –––––– 2B90.2Y Other specified malignant neoplasm of transverse colon –––––– 2B90.2Z Malignant neoplasm of transverse colon, unspecified –––––– 2B90.30 Adenocarcinoma of sigmoid colon –––––– 2B90.3Y Other specified malignant neoplasm of sigmoid colon –––––– 2B90.3Z Malignant neoplasm of sigmoid colon, unspecified –––– 2B91 Malignant neoplasms of rectosigmoid junction ––––– 2B91.0 Adenocarcinoma of rectosigmoid junction ––––– 2B91.Y Other specified malignant neoplasms of rectosigmoid junction ––––– 2B91.Z Malignant neoplasms of rectosigmoid junction, unspecified –––– 2B92 Malignant neoplasms of rectum ––––– 2B92.0 Adenocarcinomas of rectum ––––– 2B92.1 Neuroendocrine neoplasms of rectum ––––– 2B92.Y Other specified malignant neoplasms of rectum ––––– 2B92.Z Malignant neoplasms of rectum, unspecified –––– 2B93 Malignant neoplasms of large intestine, site unspecified ––––– 2B93.0 Adenocarcinoma of large intestine, site unspecified ––––– 2B93.Y Other specified malignant neoplasms of large intestine, site unspecified ––––– 2B93.Z Malignant neoplasms of large intestine, site and type unspecified –––– 2B9Y Other specified malignant neoplasms of large intestine ––– 2C00 Malignant neoplasms of anus or anal canal –––– 2C00.0 Adenocarcinoma of anus or anal canal –––– 2C00.1 Melanoma of anus or anal canal –––– 2C00.2 Neuroendocrine neoplasm of anus or anal canal –––– 2C00.3 Squamous cell carcinoma of anus or anal canal –––– 2C00.Y Other specified malignant neoplasms of anus and anal canal –––– 2C00.Z Malignant neoplasms of anus or anal canal, unspecified ––– 2C0Y Other specified malignant neoplasms of intestine ––– 2C0Z Malignant neoplasms of intestine, unspecified –– 2C10 Malignant neoplasm of pancreas ––– 2C10.0 Adenocarcinoma of pancreas ––– 2C10.1 Neuroendocrine neoplasms of pancreas ––– 2C10.Y Other specified malignant neoplasms of pancreas ––– 2C10.Z Malignant neoplasm of pancreas, unspecified –– 2C11 Malignant neoplasms of other or ill-defined digestive organs ––– 2C11.0 Adenocarcinoma of other or ill-defined digestive organs ––– 2C11.1 Mucinous carcinoma of other or ill-defined digestive organs ––– 2C11.2 Other specified malignant neoplasms of other or ill-defined digestive organs ––– 2C11.Z Malignant neoplasms of other or ill-defined digestive organs, unspecified –– 2C12 Malignant neoplasms of liver or intrahepatic bile ducts ––– 2C12.0 Malignant neoplasm of liver ––– 2C12.1 Malignant neoplasm of intrahepatic bile ducts –––– 2C12.00 Combined hepatocellular-cholangiocarcinoma –––– 2C12.01 Hepatoblastoma –––– 2C12.02 Hepatocellular carcinoma of liver –––– 2C12.03 Mesothelial carcinoma of liver –––– 2C12.0Y Other specified malignant neoplasm of liver –––– 2C12.0Z Malignant neoplasm of liver, unspecified –––– 2C12.10 Intrahepatic cholangiocarcinoma –––– 2C12.1Y Other specified malignant neoplasms of intrahepatic bile ducts –––– 2C12.1Z Malignant neoplasm of intrahepatic bile ducts, unspecified –– 2C13 Malignant neoplasms of gallbladder ––– 2C13.0 Adenocarcinoma of the gallbladder ––– 2C13.Y Other specified malignant neoplasm of gallbladder ––– 2C13.Z Malignant neoplasms of gallbladder, unspecified –– 2C14 Malignant neoplasms of proximal biliary tract, cystic duct ––– 2C14.0 Adenocarcinoma of proximal biliary tract, cystic duct ––– 2C14.1 Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct ––– 2C14.2 Neuroendocrine neoplasms of cystic duct ––– 2C14.Y Other specified malignant neoplasms of biliary tract, cystic duct ––– 2C14.Z Malignant neoplasms of proximal biliary tract, cystic duct, unspecified –– 2C15 Malignant neoplasms of biliary tract, distal bile duct ––– 2C15.0 Adenocarcinoma of biliary tract, distal bile duct ––– 2C15.1 Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct ––– 2C15.2 Neuroendocrine neoplasms of distal bile duct ––– 2C15.Y Other specified malignant neoplasms of biliary tract, distal bile duct ––– 2C15.Z Malignant neoplasms of biliary tract, distal bile duct, unspecified –– 2C16 Malignant neoplasms of ampulla of Vater ––– 2C16.0 Adenocarcinoma of ampulla of Vater ––– 2C16.1 Neuroendocrine neoplasms of ampulla of Vater ––– 2C16.Y Other specified malignant neoplasms of ampulla of Vater ––– 2C16.Z Malignant neoplasms of ampulla of Vater, unspecified –– 2C17 Malignant neoplasms of other or unspecified parts of biliary tract ––– 2C17.0 Adenocarcinoma of other or unspecified parts of biliary tract ––– 2C17.1 Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract ––– 2C17.2 Neuroendocrine neoplasms of other or unspecified parts of biliary tract ––– 2C17.Y Other specified malignant neoplasms of overlapping lesion of biliary tract ––– 2C17.Z Malignant neoplasms of other or unspecified parts of biliary tract, unspecified –– 2C18 Malignant neoplasms of perihilar bile duct ––– 2C18.0 Hilar cholangiocarcinoma ––– 2C18.1 Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct ––– 2C18.2 Neuroendocrine neoplasm of perihilar bile duct ––– 2C18.Y Other specified malignant neoplasms of perihilar bile duct ––– 2C18.Z Malignant neoplasms of perihilar bile duct, unspecified –– 2C1Z Malignant neoplasms of digestive organs, unspecified –– 2C20 Malignant neoplasms of nasal cavity ––– 2C20.0 Adenocarcinoma of nasal cavity ––– 2C20.1 Malignant neuroepitheliomatous neoplasm of nasal cavity ––– 2C20.2 Melanoma of nasal cavity ––– 2C20.3 Olfactory neuroblastoma ––– 2C20.4 Squamous cell carcinoma of nasal cavity ––– 2C20.Y Other specified malignant neoplasm of nasal cavity ––– 2C20.Z Malignant neoplasms of nasal cavity, unspecified –– 2C21 Malignant neoplasms of middle ear ––– 2C21.0 Adenocarcinoma of middle ear ––– 2C21.1 Squamous cell carcinoma of middle ear ––– 2C21.2 Unspecified malignant epithelial neoplasm of middle ear ––– 2C21.Y Other specified malignant neoplasm of middle ear ––– 2C21.Z Malignant neoplasms of middle ear, unspecified –– 2C22 Malignant neoplasms of accessory sinuses ––– 2C22.0 Adenocarcinoma of accessory sinuses ––– 2C22.1 Squamous cell carcinoma of accessory sinuses ––– 2C22.2 Malignant epithelial neoplasms of accessory sinuses, unspecified type ––– 2C22.3 Melanomas of accessory sinuses ––– 2C22.Y Other specified malignant neoplasms of accessory sinuses ––– 2C22.Z Malignant neoplasms of accessory sinuses, unspecified –––– 2C22.10 Squamous cell carcinoma of sphenoidal sinus –––– 2C22.1Y Squamous cell carcinoma of other specified accessory sinuses –– 2C23 Malignant neoplasms of larynx ––– 2C23.1 Malignant neoplasms of glottis of larynx ––– 2C23.2 Malignant neoplasms of supraglottis of larynx ––– 2C23.3 Malignant neoplasms of subglottis of larynx ––– 2C23.4 Malignant neoplasm of laryngeal cartilage ––– 2C23.5 Malignant neoplasm of overlapping lesion of larynx ––– 2C23.Z Malignant neoplasms of larynx, unspecified –––– 2C23.10 Squamous cell carcinoma of larynx, glottis –––– 2C23.1Y Other specified malignant neoplasms of larynx, glottis –––– 2C23.20 Squamous cell carcinoma of larynx, supraglottis –––– 2C23.2Y Other specified malignant neoplasms of larynx, supraglottis –––– 2C23.30 Squamous cell carcinoma of larynx, subglottis –––– 2C23.31 Adenocarcinoma of larynx, subglottis –––– 2C23.3Y Other specified malignant neoplasms of larynx, subglottis –– 2C24 Malignant neoplasms of trachea ––– 2C24.0 Adenocarcinoma of trachea ––– 2C24.1 Squamous cell carcinoma of trachea ––– 2C24.2 Malignant epithelial neoplasms of trachea, unspecified type ––– 2C24.Y Other specified malignant neoplasms of trachea ––– 2C24.Z Malignant neoplasms of trachea, unspecified –– 2C25 Malignant neoplasms of bronchus or lung ––– 2C25.0 Adenocarcinoma of bronchus or lung ––– 2C25.1 Small cell carcinoma of bronchus or lung ––– 2C25.2 Squamous cell carcinoma of bronchus or lung ––– 2C25.3 Large cell carcinoma of bronchus or lung ––– 2C25.4 Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung ––– 2C25.5 Unspecified malignant epithelial neoplasm of bronchus or lung ––– 2C25.Y Other specified malignant neoplasms of bronchus or lung ––– 2C25.Z Malignant neoplasms of bronchus or lung, unspecified –– 2C26 Malignant neoplasms of the pleura ––– 2C26.0 Mesothelioma of pleura ––– 2C26.Y Other specified malignant neoplasms of the pleura ––– 2C26.Z Malignant neoplasms of the pleura, unspecified –– 2C27 Malignant neoplasms of thymus ––– 2C27.0 Carcinoma of thymus ––– 2C27.1 Carcinoid tumour or other neuroendocrine neoplasms of thymus ––– 2C27.2 Malignant thymoma ––– 2C27.Y Other specified malignant neoplasms of thymus ––– 2C27.Z Malignant neoplasms of thymus, unspecified –– 2C28 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.0 Malignant germ cell neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.1 Other specified malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.Z Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura, unspecified –– 2C29 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.0 Squamous cell carcinomas of other and ill-defined sites in the respiratory system and intrathoracic organs ––– 2C29.1 Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.Z Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified –– 2C2Y Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs –– 2C2Z Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified –– 2C30 Melanoma of skin ––– 2C30.0 Superficial spreading melanoma, primary ––– 2C30.1 Nodular melanoma, primary ––– 2C30.2 Lentigo maligna melanoma, primary ––– 2C30.3 Acral lentiginous melanoma, primary ––– 2C30.Y Other specified melanoma of skin ––– 2C30.Z Melanoma of skin, unspecified –– 2C31 Squamous cell carcinoma of skin ––– 2C31.0 Verrucous squamous cell carcinoma of skin ––– 2C31.1 Keratoacanthoma ––– 2C31.Z Cutaneous squamous cell carcinoma –– 2C32 Basal cell carcinoma of skin ––– 2C32.0 Nodular basal cell carcinoma of skin ––– 2C32.1 Sclerosing basal cell carcinoma of skin ––– 2C32.2 Superficial basal cell carcinoma of skin ––– 2C32.Y Other specified basal cell carcinoma of skin ––– 2C32.Z Basal cell carcinoma of skin, unspecified –– 2C33 Adnexal carcinoma of skin –– 2C34 Cutaneous neuroendocrine carcinoma –– 2C35 Cutaneous sarcoma –– 2C3Y Other specified malignant neoplasms of skin –– 2C3Z Malignant neoplasm of skin of unknown or unspecified type –– 2C40 Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system –– 2C41 Malignant perineurioma –– 2C4Y Other specified malignant neoplasms of peripheral nerves and autonomic nervous system –– 2C4Z Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified –– 2C50 Malignant neoplasms of retroperitoneum ––– 2C50.0 Cystic, mucinous or serous carcinoma of retroperitoneum ––– 2C50.Y Other specified malignant neoplasms of retroperitoneum ––– 2C50.Z Malignant neoplasms of retroperitoneum, unspecified –– 2C51 Malignant neoplasms of peritoneum ––– 2C51.0 Adenocarcinomas of peritoneum ––– 2C51.1 Cystic, mucinous or serous carcinoma of peritoneum ––– 2C51.2 Mesotheliomas of peritoneum ––– 2C51.Y Other specified malignant neoplasms of peritoneum ––– 2C51.Z Malignant neoplasms of peritoneum, unspecified –––– 2C51.20 Mesothelioma of mesocolon –––– 2C51.21 Mesothelioma of mesentery –––– 2C51.2Y Mesotheliomas of other specified sites of peritoneum –––– 2C51.2Z Mesotheliomas of peritoneum, site unspecified –– 2C52 Malignant neoplasms of omentum ––– 2C52.0 Cystic, mucinous or serous carcinoma of omentum ––– 2C52.Y Other specified malignant neoplasms of omentum ––– 2C52.Z Malignant neoplasms of omentum, unspecified –– 2C53 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.0 Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.1 Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Y Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Z Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified –– 2C5Y Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum –– 2C5Z Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified –– 2C60 Carcinoma of breast, specialised type –– 2C61 Invasive carcinoma of breast ––– 2C61.0 Invasive ductal carcinoma of breast ––– 2C61.1 Invasive lobular carcinoma of breast ––– 2C61.2 Invasive pleomorphic lobular carcinoma of breast ––– 2C61.3 Invasive carcinoma of breast with mixed ductal and lobular features ––– 2C61.4 Invasive carcinoma of breast, unidentifiable type –– 2C62 Inflammatory carcinoma of breast –– 2C63 Malignant phyllodes tumour of breast –– 2C64 Solid papillary carcinoma of breast with evidence of invasion –– 2C65 Hereditary breast and ovarian cancer syndrome –– 2C6Y Other specified malignant neoplasms of breast –– 2C6Z Malignant neoplasms of breast, unspecified –– 2C70 Malignant neoplasms of vulva ––– 2C70.0 Basal cell carcinoma of vulva ––– 2C70.1 Melanoma of vulva ––– 2C70.2 Squamous cell carcinoma of vulva ––– 2C70.Y Other specified malignant neoplasms of vulva ––– 2C70.Z Malignant neoplasms of vulva, unspecified –– 2C71 Malignant neoplasms of vagina ––– 2C71.0 Adenocarcinoma of vagina ––– 2C71.1 Melanoma of vagina ––– 2C71.2 Squamous cell carcinoma of vagina ––– 2C71.Y Other specified malignant neoplasms of vagina ––– 2C71.Z Malignant neoplasms of vagina, unspecified –– 2C72 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa ––– 2C72.0 Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.1 Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.3 Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa ––– 2C72.Y Other specified malignant neoplasms of uterine ligament, parametrium, and uterine adnexa ––– 2C72.Z Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified –– 2C73 Malignant neoplasms of ovary ––– 2C73.0 Carcinomas of ovary ––– 2C73.1 Dysgerminoma of ovary ––– 2C73.2 Granulosa cell malignant tumour of ovary ––– 2C73.3 Malignant teratoma of ovary ––– 2C73.4 Serous cystadenoma, borderline malignancy of ovary ––– 2C73.5 Endodermal sinus tumour, unspecified site, female ––– 2C73.Y Other specified malignant neoplasms of the ovary ––– 2C73.Z Malignant neoplasms of ovary, unspecified –––– 2C73.00 Clear cell adenocarcinoma of ovary –––– 2C73.01 Endometrioid adenocarcinoma of ovary –––– 2C73.02 Low grade serous adenocarcinoma of ovary –––– 2C73.03 High grade serous adenocarcinoma of ovary –––– 2C73.04 Mucinous adenocarcinoma of ovary –––– 2C73.0Y Other specified carcinomas of ovary –––– 2C73.0Z Carcinomas of ovary, unspecified –– 2C74 Malignant neoplasms of fallopian tube ––– 2C74.0 Adenocarcinoma of fallopian tube ––– 2C74.Y Other specified malignant neoplasms of fallopian tube ––– 2C74.Z Malignant neoplasms of fallopian tube, unspecified –– 2C75 Malignant neoplasms of placenta ––– 2C75.0 Malignant trophoblastic neoplasms of placenta ––– 2C75.Y Other specified malignant neoplasms of placenta ––– 2C75.Z Malignant neoplasms of placenta, unspecified –– 2C76 Malignant neoplasms of corpus uteri ––– 2C76.0 Endometrial endometrioid adenocarcinoma ––– 2C76.1 Endometrial mucinous adenocarcinoma ––– 2C76.2 Endometrial clear cell adenocarcinoma ––– 2C76.3 Endometrial serous adenocarcinoma ––– 2C76.4 Endometrial mixed adenocarcinoma ––– 2C76.Y Other specified malignant neoplasms of corpus uteri ––– 2C76.Z Malignant neoplasms of corpus uteri, unspecified –––– 2C76.40 Endometrial squamous cell carcinoma –––– 2C76.41 Endometrial small cell carcinoma –––– 2C76.42 Endometrial undifferentiated carcinoma –––– 2C76.43 Carcinosarcoma of uterus –––– 2C76.4Z Endometrial mixed adenocarcinoma, unspecified –– 2C77 Malignant neoplasms of cervix uteri ––– 2C77.0 Squamous cell carcinoma of cervix uteri ––– 2C77.1 Adenocarcinoma of cervix uteri ––– 2C77.2 Adenosquamous carcinoma of cervix uteri ––– 2C77.3 Neuroendocrine carcinoma of cervix uteri ––– 2C77.Y Other specified malignant neoplasms of cervix uteri ––– 2C77.Z Malignant neoplasms of cervix uteri, unspecified –– 2C78 Malignant neoplasms of uterus, part not specified –– 2C79 Malignant neoplasm involving overlapping sites of female genital organs –– 2C7Y Other specified malignant neoplasms of female genital organs –– 2C7Z Malignant neoplasms of female genital organs, unspecified –– 2C80 Malignant neoplasms of testis ––– 2C80.2 Germ cell tumour of testis ––– 2C80.Y Other specified malignant neoplasms of testis ––– 2C80.Z Malignant neoplasms of testis, unspecified –– 2C81 Malignant neoplasms of penis ––– 2C81.0 Squamous cell carcinoma of penis ––– 2C81.1 Melanoma of penis ––– 2C81.Y Other specified malignant neoplasm of penis ––– 2C81.Z Malignant neoplasms of penis, unspecified –– 2C82 Malignant neoplasms of prostate ––– 2C82.0 Adenocarcinoma of prostate ––– 2C82.Y Other specified malignant neoplasms of prostate ––– 2C82.Z Malignant neoplasms of prostate, unspecified –– 2C83 Malignant neoplasms of scrotum ––– 2C83.0 Squamous cell carcinoma of scrotum ––– 2C83.Y Other specified malignant neoplasms of scrotum ––– 2C83.Z Malignant neoplasms of scrotum, unspecified –– 2C84 Malignant neoplasms of other specified male genital organs –– 2C8Z Malignant neoplasms of male genital organs, unspecified –– 2C90 Malignant neoplasms of kidney, except renal pelvis ––– 2C90.0 Renal cell carcinoma of kidney, except renal pelvis ––– 2C90.Y Other specified malignant neoplasms of kidney, except renal pelvis ––– 2C90.Z Malignant neoplasms of kidney, except renal pelvis, unspecified –– 2C91 Malignant neoplasms of renal pelvis ––– 2C91.0 Urothelial carcinoma of renal pelvis ––– 2C91.Y Other specified malignant neoplasms of renal pelvis ––– 2C91.Z Malignant neoplasms of renal pelvis, unspecified –– 2C92 Malignant neoplasms of ureter ––– 2C92.0 Urothelial carcinoma of ureter ––– 2C92.Y Other specified malignant neoplasms of ureter ––– 2C92.Z Malignant neoplasms of ureter, unspecified –– 2C93 Malignant neoplasms of urethra or paraurethral gland ––– 2C93.0 Adenocarcinoma of urethra or paraurethral gland ––– 2C93.1 Squamous cell carcinoma of urethra or paraurethral gland ––– 2C93.2 Urothelial carcinoma of urethra or paraurethral gland ––– 2C93.Y Other specified malignant neoplasms of urethra and paraurethral gland ––– 2C93.Z Malignant neoplasms of urethra or paraurethral gland, unspecified –– 2C94 Malignant neoplasms of bladder ––– 2C94.0 Adenocarcinoma of urinary bladder ––– 2C94.1 Squamous cell carcinoma of urinary bladder ––– 2C94.2 Urothelial carcinoma of bladder ––– 2C94.Y Other specified malignant neoplasms of bladder ––– 2C94.Z Malignant neoplasms of bladder, unspecified –– 2C95 Malignant neoplasm involving overlapping sites of urinary organs ––– 2C95.0 Adenocarcinoma involving overlapping sites of urinary organs ––– 2C95.1 Squamous cell carcinomas involving overlapping sites of urinary organs ––– 2C95.2 Urothelial carcinoma involving overlapping sites of urinary organs ––– 2C95.Y Other specified malignant neoplasms of overlapping lesion of urinary organs ––– 2C95.Z Malignant neoplasm involving overlapping sites of urinary organs, unspecified –– 2C9Y Other specified malignant neoplasms of urinary tract –– 2C9Z Malignant neoplasms of urinary tract, unspecified –– 2D00 Malignant neoplasm of conjunctiva ––– 2D00.0 Melanoma of conjunctiva ––– 2D00.1 Malignant neoplasm of caruncle ––– 2D00.2 Squamous cell carcinoma of conjunctiva ––– 2D00.Y Other specified malignant neoplasm of conjunctiva ––– 2D00.Z Malignant neoplasm of conjunctiva, unspecified –– 2D01 Malignant neoplasm of cornea ––– 2D01.0 Melanoma of cornea ––– 2D01.1 Squamous cell carcinoma of cornea ––– 2D01.Y Other specified malignant neoplasms of cornea ––– 2D01.Z Malignant neoplasm of cornea, unspecified –– 2D02 Malignant neoplasm of retina ––– 2D02.0 Adenocarcinoma of retinal pigment epithelium ––– 2D02.1 Malignant neuroepithelial tumours of retina ––– 2D02.2 Retinoblastoma ––– 2D02.Y Other specified malignant neoplasm of retina ––– 2D02.Z Malignant neoplasm of retina, unspecified –– 2D03 Malignant neoplasm of lacrimal apparatus ––– 2D03.0 Adenocarcinoma of the lacrimal apparatus ––– 2D03.1 Mucoepidermoid carcinoma of lacrimal apparatus ––– 2D03.2 Squamous cell carcinoma of the lacrimal apparatus ––– 2D03.Y Other specified malignant neoplasm of lacrimal apparatus ––– 2D03.Z Malignant neoplasm of lacrimal apparatus, unspecified –– 2D04 Malignant neoplasm of orbit –– 2D05 Malignant neoplasm of choroid ––– 2D05.0 Melanoma of choroid ––– 2D05.Y Other specified malignant neoplasm of choroid ––– 2D05.Z Malignant neoplasm of choroid, unspecified –– 2D06 Malignant neoplasm of ciliary body ––– 2D06.0 Adenocarcinoma of ciliary epithelium ––– 2D06.1 Malignant medulloepithelioma of ciliary body ––– 2D06.3 Malignant neuroepithelial tumours of ciliary body ––– 2D06.4 Melanoma of ciliary body ––– 2D06.Y Other specified malignant neoplasm of ciliary body ––– 2D06.Z Malignant neoplasm of ciliary body, unspecified –– 2D07 Malignant neoplasm of iris ––– 2D07.0 Adenocarcinoma of iris epithelium ––– 2D07.1 Malignant neuroepithelial tumours of iris ––– 2D07.2 Melanoma of iris ––– 2D07.Y Other specified malignant neoplasm of iris ––– 2D07.Z Malignant neoplasm of iris, unspecified –– 2D0Y Other specified malignant neoplasms of eye and ocular adnexa –– 2D0Z Malignant neoplasms of eye or ocular adnexa, unspecified –– 2D10 Malignant neoplasms of thyroid gland ––– 2D10.0 Follicular carcinoma of thyroid gland ––– 2D10.1 Papillary carcinoma of thyroid gland ––– 2D10.2 Poorly differentiated carcinoma of thyroid gland ––– 2D10.3 Undifferentiated carcinoma of thyroid gland ––– 2D10.4 Medullary carcinoma of thyroid gland ––– 2D10.Y Other specified malignant neoplasms of thyroid gland ––– 2D10.Z Malignant neoplasms of thyroid gland, unspecified –– 2D11 Malignant neoplasms of adrenal gland ––– 2D11.0 Adenocarcinoma of adrenal gland ––– 2D11.1 Malignant phaeochromocytoma of adrenal gland ––– 2D11.2 Neuroblastoma of adrenal gland ––– 2D11.Y Other specified malignant neoplasms of adrenal gland ––– 2D11.Z Malignant neoplasms of adrenal gland, unspecified –– 2D12 Malignant neoplasms of other endocrine glands or related structures ––– 2D12.0 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type ––– 2D12.1 Adenocarcinoma of other endocrine glands or related structures ––– 2D12.Y Other specified malignant neoplasms of other endocrine glands or related structures ––– 2D12.Z Malignant neoplasms of other endocrine glands or related structures, unspecified –– 2D1Z Malignant neoplasms of endocrine glands, unspecified – 2D3Y Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues – 2D3Z Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified – 2D40 Adenocarcinoma of unspecified site – 2D41 Unspecified carcinoma of unspecified site – 2D42 Malignant neoplasms of ill-defined sites – 2D43 Malignant neoplasms of independent, multiple primary sites – 2D44 Malignant neoplasm, primary site unknown, so stated – 2D4Y Other specified malignant neoplasms of unspecified primary sites – 2D4Z Unspecified malignant neoplasms of unspecified sites – 2D50 Malignant neoplasm metastasis in brain – 2D51 Malignant neoplasm metastasis in meninges – 2D52 Malignant neoplasm metastasis in spinal cord, cranial nerves or remaining parts of central nervous system –– 2D60 Malignant neoplasm metastasis in lymph node of a single region ––– 2D60.0 Malignant neoplasm metastasis in lymph nodes of head, face or neck ––– 2D60.1 Malignant neoplasm metastasis in intrathoracic lymph nodes ––– 2D60.2 Malignant neoplasm metastasis in intra-abdominal lymph nodes ––– 2D60.3 Malignant neoplasm metastasis in axillary lymph nodes ––– 2D60.4 Malignant neoplasm metastasis in inguinal lymph nodes ––– 2D60.5 Malignant neoplasm metastasis in intrapelvic lymph nodes ––– 2D60.Y Other specified malignant neoplasm metastasis in lymph node of a single region ––– 2D60.Z Malignant neoplasm metastasis in lymph node of a single region, unspecified –– 2D61 Malignant neoplasm metastases in lymph nodes of multiple regions –– 2D6Z Metastatic malignant neoplasm to unspecified lymph node –– 2D70 Malignant neoplasm metastasis in lung –– 2D71 Malignant neoplasm metastasis in mediastinum –– 2D72 Malignant neoplasm metastasis in pleura –– 2D73 Malignant neoplasm metastasis in upper respiratory tract organs –– 2D7Y Malignant neoplasm metastasis in other specified thoracic organs –– 2D7Z Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified –– 2D80 Malignant neoplasm metastasis in liver or intrahepatic bile duct ––– 2D80.0 Malignant neoplasm metastasis in liver ––– 2D80.1 Malignant neoplasm metastasis in intrahepatic bile duct –– 2D81 Malignant neoplasm metastasis in pancreas –– 2D82 Malignant neoplasm metastasis in extrahepatic bile ducts –– 2D83 Malignant neoplasm metastasis in ampulla of Vater –– 2D84 Malignant neoplasm metastasis in the small intestine –– 2D85 Malignant neoplasm metastasis in large intestine –– 2D86 Malignant neoplasm metastasis in anus –– 2D8Y Malignant neoplasm metastasis in other specified digestive system organ –– 2D8Z Malignant neoplasm metastasis in unspecified digestive system organ –– 2D90 Malignant neoplasm metastasis in retroperitoneum –– 2D91 Malignant neoplasm metastasis in peritoneum –– 2E00 Malignant neoplasm metastasis in kidney or renal pelvis –– 2E01 Malignant neoplasm metastasis in bladder –– 2E02 Malignant neoplasm metastasis in other or unspecified urinary system organs –– 2E03 Malignant neoplasm metastasis in bone or bone marrow –– 2E04 Malignant neoplasm metastasis in soft tissue –– 2E05 Malignant neoplasm metastasis in female reproductive system ––– 2E05.0 Malignant neoplasm metastasis in ovary ––– 2E05.Y Malignant neoplasm metastasis in other female reproductive system organs ––– 2E05.Z Malignant neoplasm metastasis in female reproductive system, unspecified –– 2E06 Malignant neoplasm metastasis in male genital organs –– 2E07 Malignant neoplasm metastasis in adrenal gland –– 2E08 Metastatic malignant neoplasm involving skin –– 2E09 Malignant neoplasm metastasis in peripheral nervous system –– 2E0Y Malignant neoplasm metastasis in other specified sites – 2E2Z Malignant neoplasm metastasis, unspecified 2E60 Carcinoma in situ of oral cavity, oesophagus or stomach – 2E60.0 Carcinoma in situ of lip, oral cavity or pharynx – 2E60.1 Carcinoma in situ of oesophagus – 2E60.2 Carcinoma in situ of stomach 2E61 Carcinoma in situ of other or unspecified digestive organs – 2E61.0 Carcinoma in situ of colon – 2E61.1 Carcinoma in situ of rectum – 2E61.2 Carcinoma in situ of anal canal – 2E61.3 Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater – 2E61.Y Carcinoma in situ of other specified digestive organs – 2E61.Z Carcinoma in situ of unspecified digestive organs 2E62 Carcinoma in situ of middle ear or respiratory system – 2E62.0 Carcinoma in situ of larynx – 2E62.1 Carcinoma in situ of trachea – 2E62.2 Carcinoma in situ of bronchus or lung – 2E62.Y Carcinoma in situ of other specified sites of middle ear and respiratory system – 2E62.Z Carcinoma in situ of unspecified sites of middle ear and respiratory system 2E63 Melanoma in situ neoplasms – 2E63.0 Melanoma in situ of skin – 2E63.1 Melanoma in situ of conjunctiva – 2E63.Y Melanoma in situ neoplasms, other specified site – 2E63.Z Melanoma in situ neoplasms, unspecified site –– 2E63.00 Lentigo maligna –– 2E63.0Z Melanoma in situ of skin, unspecified 2E64 Carcinoma in situ of skin – 2E64.0 Intraepidermal squamous cell carcinoma – 2E64.1 Extramammary Paget disease of skin – 2E64.2 Carcinoma in situ of anal margin or perianal skin – 2E64.Y Other specified carcinoma in situ of skin – 2E64.Z Carcinoma in situ of skin, unspecified –– 2E64.00 Bowen disease of skin –– 2E64.01 Actinic intraepidermal squamous cell carcinoma –– 2E64.0Y Other specified intraepidermal squamous cell carcinoma –– 2E64.0Z Intraepidermal squamous cell carcinoma, unspecified 2E65 Carcinoma in situ of breast – 2E65.0 Lobular carcinoma in situ of breast – 2E65.1 Lobular carcinoma in situ of breast, pleomorphic subtype – 2E65.2 Ductal carcinoma in situ of breast – 2E65.3 Ductal carcinoma in situ of breast, comedo subtype – 2E65.4 Mixed ductal and lobular carcinoma in situ of breast – 2E65.5 Paget disease of nipple – 2E65.Y Other specified carcinoma in situ of breast – 2E65.Z Carcinoma in situ of breast, unspecified 2E66 Carcinoma in situ of cervix uteri – 2E66.2 High grade squamous intraepithelial lesion of cervix uteri – 2E66.Y Other specified carcinoma in situ of cervix uteri – 2E66.Z Carcinoma in situ of cervix uteri, unspecified 2E67 Carcinoma in situ of other or unspecified genital organs – 2E67.0 Carcinoma in situ of endometrium – 2E67.1 Carcinoma in situ of vulva – 2E67.2 Carcinoma in situ of vagina – 2E67.3 Carcinoma in situ of other or unspecified female genital organs – 2E67.4 Carcinoma in situ of penis – 2E67.5 High grade intraepithelial lesion of prostate – 2E67.6 Carcinoma in situ of other or unspecified male genital organs –– 2E67.11 Vulvar Paget disease –– 2E67.12 Vulvar intraepithelial neoplasia, HPV-independent –– 2E67.13 High grade squamous intraepithelial lesion of vulva, HPV-associated –– 2E67.22 High grade squamous intraepithelial lesion of vagina –– 2E67.2Y Other specified carcinoma in situ of vagina –– 2E67.2Z Carcinoma in situ of vagina, unspecified –– 2E67.40 Squamous cell carcinoma in situ of skin of penis –– 2E67.41 Squamous cell carcinoma in situ of mucocutaneous epithelium of penis 2E68 Carcinoma in situ of bladder 2E69 Carcinoma in situ of other or unspecified urinary organs 2E6A Carcinoma in situ of the eye or ocular adnexa – 2E6A.0 Carcinoma in situ of the conjunctiva – 2E6A.1 Carcinoma in situ of the cornea – 2E6A.Y Carcinoma in situ of other and unspecified part of the eye and adnexa 2E6B Carcinoma in situ of thyroid and other endocrine glands 2E6Y Carcinoma in situ of other specified site 2E6Z Carcinoma in situ of unspecified site – 2E80 Benign lipomatous neoplasm –– 2E80.0 Lipoma –– 2E80.1 Lipoblastoma –– 2E80.Y Other specified benign lipomatous neoplasm –– 2E80.Z Benign lipomatous neoplasm, unspecified ––– 2E80.00 Superficial subcutaneous lipoma ––– 2E80.01 Deep subfascial lipoma ––– 2E80.02 Deep internal or visceral lipoma ––– 2E80.0Y Lipoma, other specified site ––– 2E80.0Z Lipoma, unspecified site – 2E81 Benign vascular neoplasms –– 2E81.0 Neoplastic haemangioma –– 2E81.1 Benign lymphatic neoplasms –– 2E81.2 Benign vascular neoplasms of infancy and childhood –– 2E81.Y Other specified benign vascular neoplasms –– 2E81.Z Benign vascular neoplasms, unspecified ––– 2E81.00 Umbilical cord haemangioma ––– 2E81.01 Conjunctival haemangioma or haemolymphangioma ––– 2E81.0Y Neoplastic haemangioma of other specified site ––– 2E81.0Z Neoplastic haemangioma, unspecified site ––– 2E81.10 Disseminated lymphangiomatosis ––– 2E81.11 Acquired progressive lymphangioma ––– 2E81.1Y Other specified benign lymphatic neoplasms ––– 2E81.1Z Benign lymphatic neoplasms, unspecified ––– 2E81.20 Focal infantile haemangioma ––– 2E81.21 Multifocal infantile haemangioma ––– 2E81.2Y Other specified benign vascular neoplasms of infancy and childhood ––– 2E81.2Z Benign vascular neoplasms of infancy and childhood, unspecified – 2E82 Benign chondrogenic tumours –– 2E82.0 Benign chondrogenic tumours of bone or articular cartilage of limbs –– 2E82.1 Benign chondrogenic tumours of bone or articular cartilage of other specified sites –– 2E82.Z Benign chondrogenic tumours, site unspecified – 2E83 Benign osteogenic tumours –– 2E83.0 Benign osteogenic tumours of bone or articular cartilage of skull or face –– 2E83.1 Benign osteogenic tumours of bone or articular cartilage of lower jaw –– 2E83.2 Benign osteogenic tumours of bone or articular cartilage of vertebral column –– 2E83.3 Benign osteogenic tumours of bone or articular cartilage of ribs, sternum or clavicle –– 2E83.4 Benign osteogenic tumours of bone or articular cartilage of pelvic bones, sacrum or coccyx –– 2E83.5 Benign osteogenic tumours of bone or articular cartilage of limbs –– 2E83.Y Benign osteogenic tumour of other specified site –– 2E83.Z Benign osteogenic tumour of unspecified site – 2E84 Benign fibrogenic or myofibrogenic tumour –– 2E84.0 Benign fibrogenic or myofibrogenic tumour of skin –– 2E84.Y Benign fibrogenic or myofibrogenic tumour of other specified sites –– 2E84.Z Benign fibrogenic or myofibrogenic tumour, site unknown – 2E85 Benign fibrohistiocytic tumour –– 2E85.0 Benign fibrohistiocytic tumour of soft tissues of limbs –– 2E85.1 Benign fibrohistiocytic tumour of retroperitoneum or peritoneum –– 2E85.2 Benign fibrohistiocytic tumour of skin –– 2E85.Y Benign fibrohistiocytic tumour of other specified sites –– 2E85.Z Benign fibrohistiocytic tumour, site unspecified – 2E86 Benign smooth muscle or skeletal muscle tumour –– 2E86.0 Leiomyoma of uterus –– 2E86.1 Leiomyoma of other or unspecified sites –– 2E86.2 Rhabdomyoma –– 2E86.Y Other specified benign smooth muscle or skeletal muscle tumour –– 2E86.Z Benign smooth muscle or skeletal muscle tumour, unspecified – 2E87 Benign gastrointestinal stromal tumour – 2E88 Benign endometrial stromal nodule – 2E89 Benign mesenchymal tumours of uncertain differentiation –– 2E89.0 Benign tumours of uncertain differentiation, bone or cartilage –– 2E89.1 Benign tumours of uncertain differentiation, soft tissue –– 2E89.Y Benign mesenchymal tumours of uncertain differentiation of other specified site –– 2E89.Z Benign mesenchymal tumours of uncertain differentiation of unspecified site – 2E8A Other mixed or unspecified benign mesenchymal tumours – 2E8Y Other specified benign mesenchymal neoplasm – 2E8Z Benign mesenchymal neoplasms, unspecified – 2E90 Benign neoplasm of lip, oral cavity or pharynx –– 2E90.0 Benign neoplasm of lip –– 2E90.1 Benign neoplasm of tongue –– 2E90.2 Benign neoplasm of floor of mouth –– 2E90.3 Benign neoplasm of other or unspecified parts of mouth –– 2E90.4 Benign neoplasm of tonsil –– 2E90.5 Benign neoplasm of oropharynx –– 2E90.6 Benign neoplasm of nasopharynx –– 2E90.7 Benign neoplasm of hypopharynx –– 2E90.8 Benign neoplasm of pharynx, unspecified – 2E91 Benign neoplasm of major salivary glands –– 2E91.0 Benign neoplasm of parotid gland –– 2E91.1 Benign neoplasm of other specified major salivary glands –– 2E91.Z Benign neoplasm of unspecified major salivary glands – 2E92 Benign neoplasm of digestive organs –– 2E92.0 Benign neoplasm of oesophagus –– 2E92.1 Benign neoplasm of stomach –– 2E92.2 Benign neoplasm of duodenum –– 2E92.3 Benign neoplasm of other or unspecified parts of small intestine –– 2E92.4 Benign neoplasm of the large intestine –– 2E92.5 Benign neoplasm of anus or anal canal –– 2E92.6 Benign neoplasm of gallbladder, extrahepatic bile ducts or ampulla of Vater –– 2E92.7 Benign neoplasm of liver or intrahepatic bile ducts –– 2E92.8 Benign neoplasm of pancreas –– 2E92.9 Benign neoplasm of endocrine pancreas –– 2E92.Y Benign neoplasm of other specified digestive organs –– 2E92.Z Benign neoplasm of unspecified digestive organs ––– 2E92.40 Polyposis syndrome ––– 2E92.4Y Other specified benign neoplasm of the large intestine ––– 2E92.4Z Benign neoplasm of the large intestine, unspecified –– 2F00 Benign neoplasm of middle ear or respiratory system ––– 2F00.0 Middle ear endocrine tumour ––– 2F00.1 Recurrent respiratory papillomatosis ––– 2F00.2 Laryngeal endocrine tumour ––– 2F00.Y Other specified benign neoplasm of middle ear or respiratory system ––– 2F00.Z Benign neoplasm of middle ear or respiratory system, unspecified –– 2F01 Benign neoplasm of intrathoracic organs –– 2F0Y Benign neoplasms of other specified respiratory and intrathoracic organs –– 2F0Z Benign neoplasms of unspecified respiratory and intrathoracic organs – 2F10 Benign neoplasm of mesothelial tissue –– 2F20 Benign cutaneous melanocytic neoplasms ––– 2F20.0 Common acquired melanocytic naevus ––– 2F20.1 Atypical melanocytic naevus ––– 2F20.2 Congenital melanocytic naevus ––– 2F20.3 Generalised eruptive melanocytic naevi ––– 2F20.Y Other specific types of melanocytic naevus ––– 2F20.Z Melanocytic naevus, unspecified –––– 2F20.00 Multiple benign melanocytic naevi –––– 2F20.0Y Other specified common acquired melanocytic naevus –––– 2F20.0Z Common acquired melanocytic naevus, unspecified –––– 2F20.20 Giant congenital melanocytic naevus –––– 2F20.2Y Other specified congenital melanocytic naevus –––– 2F20.2Z Congenital melanocytic naevus, unspecified –– 2F21 Benign keratinocytic acanthomas ––– 2F21.0 Seborrhoeic keratosis ––– 2F21.Y Other specified benign keratinocytic acanthomas –– 2F22 Benign neoplasms of epidermal appendages –– 2F23 Benign dermal fibrous or fibrohistiocytic neoplasms ––– 2F23.0 Dermatofibroma ––– 2F23.Y Other specified benign dermal fibrous or fibrohistiocytic neoplasms –– 2F24 Benign cutaneous neoplasms of neural or nerve sheath origin –– 2F25 Cherry angioma –– 2F26 Lobular capillary haemangioma –– 2F2Y Other specified benign cutaneous neoplasms –– 2F2Z Benign cutaneous neoplasm of unspecified type – 2F30 Benign neoplasm of breast –– 2F30.0 Tubular adenoma of breast –– 2F30.1 Lactating adenoma of breast –– 2F30.2 Intraductal papilloma of breast –– 2F30.3 Benign phyllodes tumour of breast –– 2F30.4 Fibromatosis of breast –– 2F30.5 Fibroadenoma of breast –– 2F30.6 Extensive adenomatosis of nipple –– 2F30.Y Other specified benign neoplasm of breast –– 2F30.Z Benign neoplasm of breast, unspecified – 2F31 Benign non-mesenchymal neoplasms of uterus –– 2F31.0 Benign non-mesenchymal neoplasm of uterus, cervix uteri –– 2F31.1 Benign non-mesenchymal neoplasm of uterus, corpus uteri –– 2F31.2 Benign non-mesenchymal neoplasms of uterus, other parts – 2F32 Benign neoplasm of ovary –– 2F32.0 Cystic teratoma –– 2F32.1 Ovarian fibroma –– 2F32.2 Meigs' syndrome –– 2F32.3 Serous ovarian cystadenoma –– 2F32.Y Other specified benign neoplasm of ovary –– 2F32.Z Benign neoplasm of ovary, unspecified – 2F33 Benign neoplasm of other or unspecified female genital organs – 2F34 Benign neoplasm of male genital organs – 2F35 Benign neoplasm of urinary organs – 2F36 Benign neoplasm of eye or ocular adnexa –– 2F36.0 Benign neoplasm of choroid –– 2F36.1 Benign neoplasm of iris –– 2F36.2 Benign neoplasm of ciliary body –– 2F36.3 Teratoma of orbit –– 2F36.4 Cysts of eyelid –– 2F36.Y Other specified benign neoplasm of eye or ocular adnexa –– 2F36.Z Benign neoplasm of eye or ocular adnexa, unspecified – 2F37 Benign neoplasm of endocrine glands –– 2F37.0 Non-secreting pituitary adenoma –– 2F37.Y Other specified benign neoplasm of endocrine glands –– 2F37.Z Benign neoplasm of endocrine glands, unspecified – 2F3Y Benign non-mesenchymal neoplasms of other specified site – 2F3Z Benign non-mesenchymal neoplasms of unspecified site 2F5Y Other specified benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues 2F5Z Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified 2F70 Neoplasms of uncertain behaviour of oral cavity or digestive organs – 2F70.0 Neoplasms of uncertain behaviour of lip, oral cavity or pharynx – 2F70.1 Neoplasms of uncertain behaviour of stomach – 2F70.2 Neoplasms of uncertain behaviour of small intestine – 2F70.3 Neoplasms of uncertain behaviour of colon – 2F70.4 Neoplasms of uncertain behaviour of rectum – 2F70.5 Neoplasms of uncertain behaviour of liver, gallbladder or bile ducts – 2F70.Y Neoplasms of uncertain behaviour of oral cavity and digestive organs, other specified site – 2F70.Z Neoplasms of uncertain behaviour of oral cavity and digestive organs, unspecified site 2F71 Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs – 2F71.0 Neoplasms of uncertain behaviour of thymus – 2F71.1 Neoplasms of uncertain behaviour of larynx – 2F71.2 Neoplasms of uncertain behaviour of pleura – 2F71.3 Neoplasms of uncertain behaviour of trachea, bronchus or lung – 2F71.4 Neoplasms of uncertain behaviour of mediastinum – 2F71.Y Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, other specified site – 2F71.Z Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, unspecified site 2F72 Neoplasms of uncertain behaviour of skin – 2F72.1 Spitzoid tumour of uncertain malignant potential – 2F72.2 Melanocytic naevus with severe melanocytic dysplasia – 2F72.Y Other specified neoplasms of uncertain behaviour of skin 2F73 Neoplasms of uncertain behaviour of retroperitoneum 2F74 Neoplasms of uncertain behaviour of peritoneum 2F75 Neoplasms of uncertain behaviour of breast 2F76 Neoplasms of uncertain behaviour of female genital organs 2F77 Neoplasms of uncertain behaviour of male genital organs 2F78 Neoplasms of uncertain behaviour of urinary organs 2F79 Neoplasms of uncertain behaviour of eye or ocular adnexa 2F7A Neoplasms of uncertain behaviour of endocrine glands – 2F7A.0 Multiple polyglandular tumours – 2F7A.Y Other specified neoplasms of uncertain behaviour of endocrine glands – 2F7A.Z Neoplasms of uncertain behaviour of endocrine glands, unspecified 2F7B Neoplasms of uncertain behaviour of bone or articular cartilage 2F7C Neoplasms of uncertain behaviour of connective or other soft tissue 2F7Y Neoplasms of uncertain behaviour of other specified site 2F7Z Neoplasms of uncertain behaviour of unspecified site 2F90 Neoplasms of unknown behaviour of oral cavity or digestive organs – 2F90.0 Neoplasms of unknown behaviour of colon – 2F90.1 Neoplasms of unknown behaviour of rectum – 2F90.Y Neoplasms of unknown behaviour of oral cavity and digestive organs, other specified site – 2F90.Z Neoplasms of unknown behaviour of oral cavity and digestive organs, unspecified site 2F91 Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs – 2F91.0 Neoplasms of unknown behaviour of larynx – 2F91.1 Neoplasms of unknown behaviour of trachea, bronchus or lung – 2F91.Y Neoplasms of unknown behaviour of other specified respiratory organ, intrathoracic organ or middle ear – 2F91.Z Neoplasms of unknown behaviour of unspecified respiratory organ or intrathoracic organ 2F92 Neoplasms of unknown behaviour of skin 2F93 Neoplasms of unknown behaviour of retroperitoneum 2F94 Neoplasms of unknown behaviour of peritoneum 2F95 Neoplasms of unknown behaviour of breast 2F96 Neoplasms of unknown behaviour of female genital organs 2F97 Neoplasms of unknown behaviour of male genital organs 2F98 Neoplasms of unknown behaviour of urinary organs 2F99 Neoplasms of unknown behaviour of eye or ocular adnexa 2F9A Neoplasms of unknown behaviour of endocrine glands 2F9B Neoplasms of unknown behaviour of bone or articular cartilage 2F9C Neoplasms of unknown behaviour of connective or other soft tissue 2F9Y Neoplasms of unknown behaviour of other specified site 2F9Z Neoplasms of unknown behaviour of unspecified site – 9A00 Congenital malposition of eyelids –– 9A00.0 Dystopia canthorum –– 9A00.1 Telecanthus –– 9A00.Y Other specified congenital malposition of eyelids –– 9A00.Z Congenital malposition of eyelids, unspecified – 9A01 Infectious disorders of eyelid –– 9A01.0 Preseptal cellulitis –– 9A01.1 Abscess of eyelid –– 9A01.2 Hordeolum –– 9A01.3 Infectious blepharitis –– 9A01.4 Infestation of eyelid –– 9A01.Y Other specified infectious disorders of eyelid –– 9A01.Z Unspecified infectious disorders of eyelid ––– 9A01.20 Hordeolum externum ––– 9A01.21 Hordeolum internum ––– 9A01.2Z Hordeolum, unspecified – 9A02 Inflammatory disorders of eyelid –– 9A02.0 Chalazion –– 9A02.1 Posterior blepharitis –– 9A02.2 Ligneous conjunctivitis –– 9A02.4 Meibomian gland dysfunction –– 9A02.Y Other specified inflammatory disorders of eyelid –– 9A02.Z Inflammatory disorders of eyelid, unspecified ––– 9A02.00 Chalazion externum ––– 9A02.01 Chalazion internum ––– 9A02.0Y Other specified chalazion ––– 9A02.0Z Chalazion, unspecified – 9A03 Acquired malposition of eyelid –– 9A03.0 Blepharoptosis –– 9A03.1 Entropion of eyelid –– 9A03.2 Ectropion of eyelid –– 9A03.3 Eyelid retraction –– 9A03.4 Lagophthalmos –– 9A03.5 Dermatochalasis of eyelid –– 9A03.Y Other specified acquired malposition of eyelid –– 9A03.Z Acquired malposition of eyelid, unspecified ––– 9A03.00 Marcus-Gunn syndrome ––– 9A03.01 Mechanical ptosis of eyelid ––– 9A03.02 Myogenic ptosis of eyelid ––– 9A03.03 Paralytic ptosis of eyelid ––– 9A03.0Y Other specified blepharoptosis ––– 9A03.0Z Blepharoptosis, unspecified ––– 9A03.10 Cicatricial entropion of eyelid ––– 9A03.11 Mechanical entropion of eyelid ––– 9A03.12 Senile entropion of eyelid ––– 9A03.13 Spastic entropion of eyelid ––– 9A03.1Y Other specified entropion of eyelid ––– 9A03.1Z Entropion of eyelid, unspecified ––– 9A03.20 Cicatricial ectropion of eyelid ––– 9A03.21 Mechanical ectropion of eyelid ––– 9A03.22 Senile ectropion of eyelid ––– 9A03.23 Spastic ectropion of eyelid ––– 9A03.24 Floppy eyelid syndrome ––– 9A03.2Y Other specified ectropion of eyelid ––– 9A03.2Z Ectropion of eyelid, unspecified ––– 9A03.40 Cicatricial lagophthalmos ––– 9A03.41 Mechanical lagophthalmos ––– 9A03.42 Paralytic lagophthalmos ––– 9A03.4Y Other specified lagophthalmos ––– 9A03.4Z Lagophthalmos, unspecified – 9A04 Acquired disorders of eyelashes –– 9A04.0 Trichiasis without entropion –– 9A04.1 Madarosis of eyelid or periocular area –– 9A04.Y Other specified acquired disorders of eyelashes –– 9A04.Z Acquired disorders of eyelashes, unspecified – 9A05 Movement disorders of eyelid –– 9A05.0 Myokymia of eyelid –– 9A05.1 Eyelid apraxia –– 9A05.Y Other specified movement disorders of eyelid –– 9A05.Z Movement disorders of eyelid, unspecified – 9A06 Certain specified disorders of eyelid –– 9A06.0 Involvement of eyelid by dermatosis classified elsewhere –– 9A06.1 Vitiligo of eyelid or periocular area –– 9A06.2 Symblepharon, acquired –– 9A06.3 Traumatic scar of eyelid –– 9A06.4 Xanthelasma of eyelid –– 9A06.5 Tear Trough Deformity –– 9A06.6 Sunken Sulcus Deformity –– 9A06.7 Dermatitis or eczema of eyelids –– 9A06.8 Blepharochalasis –– 9A06.Y Other specified disorders of eyelid ––– 9A06.70 Atopic eczema of eyelids ––– 9A06.71 Seborrhoeic dermatitis of eyelids ––– 9A06.72 Allergic contact blepharoconjunctivitis ––– 9A06.7Y Other specified dermatitis or eczema of eyelids ––– 9A06.7Z Dermatitis or eczema of eyelids, type unspecified – 9A0Y Other specified disorders of eyelid or peri-ocular area – 9A0Z Disorders of eyelid or peri-ocular area, unspecified – 9A10 Disorders of lacrimal gland –– 9A10.0 Infections of the lacrimal gland –– 9A10.1 Orbital inflammatory syndrome –– 9A10.2 Benign lymphoepithelial lesion of lacrimal gland –– 9A10.3 Hyperlacrimation –– 9A10.4 Underproduction of tears –– 9A10.Y Other specified disorders of lacrimal gland –– 9A10.Z Disorders of lacrimal gland, unspecified – 9A11 Disorders of lacrimal drainage system –– 9A11.0 Eversion of lacrimal punctum –– 9A11.1 Canaliculitis –– 9A11.2 Dacryocystitis –– 9A11.3 Conjunctivochalasis –– 9A11.4 Punctal stenosis –– 9A11.5 Nasolacrimal canalicular stenosis –– 9A11.6 Dacryolith –– 9A11.7 Nasolacrimal sac stenosis –– 9A11.8 Nasolacrimal duct obstruction –– 9A11.Y Other specified disorders of lacrimal drainage system –– 9A11.Z Disorders of lacrimal drainage system, unspecified – 9A1Y Other specified disorders of lacrimal apparatus – 9A1Z Disorders of lacrimal apparatus, unspecified – 9A20 Displacement of eyeball –– 9A20.0 Axial displacement of eyeball –– 9A20.1 Non-axial displacement of eyeball –– 9A20.Y Other specified displacement of eyeball –– 9A20.Z Displacement of eyeball, unspecified ––– 9A20.00 Outward displacement of eyeball ––– 9A20.01 Inward displacement of eyeball ––– 9A20.0Y Other specified axial displacement of eyeball ––– 9A20.0Z Axial displacement of eyeball, unspecified – 9A21 Orbital infection –– 9A21.0 Orbital cellulitis –– 9A21.1 Orbital subperiosteal abscess –– 9A21.2 Orbital abscess –– 9A21.3 Periostitis of orbit –– 9A21.Y Other specified orbital infection –– 9A21.Z Orbital infection, unspecified – 9A22 Orbital inflammation –– 9A22.0 Dysthyroid orbitopathy –– 9A22.1 Diffuse orbital inflammation –– 9A22.2 Granulomatous orbital inflammation –– 9A22.Y Other specified orbital inflammation –– 9A22.Z Orbital inflammation, unspecified – 9A23 Orbital cyst –– 9A23.0 Congenital orbital cyst –– 9A23.1 Acquired orbital cyst –– 9A23.Z Orbital cyst, unspecified – 9A24 Bony deformity of orbit –– 9A24.0 Contraction of orbit –– 9A24.1 Expansion of orbit –– 9A24.2 Distortion of orbit –– 9A24.3 Enlargement of bony orbit –– 9A24.4 Exostosis of orbit –– 9A24.Y Other specified bony deformity of orbit –– 9A24.Z Bony deformity of orbit, unspecified – 9A25 Soft tissue deformity of orbit –– 9A25.0 Anophthalmic socket –– 9A25.1 Microphthalmic socket –– 9A25.2 Contracted socket –– 9A25.3 Oedema of orbit –– 9A25.4 Haemorrhage of orbit –– 9A25.5 Atrophy of soft tissue of orbit –– 9A25.Y Other specified soft tissue deformity of orbit –– 9A25.Z Soft tissue deformity of orbit, unspecified – 9A26 Combined bony and soft tissue deformity of orbit – 9A2Y Other specified disorders of orbit – 9A2Z Disorders of orbit, unspecified 9A4Y Other specified disorders of the ocular adnexa or orbit 9A4Z Disorders of the ocular adnexa or orbit, unspecified – 9A60 Conjunctivitis –– 9A60.0 Papillary conjunctivitis –– 9A60.1 Follicular conjunctivitis –– 9A60.2 Cicatrizing conjunctivitis –– 9A60.3 Mucopurulent conjunctivitis –– 9A60.4 Blepharoconjunctivitis –– 9A60.5 Vernal keratoconjunctivitis –– 9A60.6 Serous conjunctivitis, except viral –– 9A60.Y Other specified conjunctivitis –– 9A60.Z Conjunctivitis, unspecified ––– 9A60.00 Giant papillary conjunctivitis ––– 9A60.01 Acute atopic conjunctivitis ––– 9A60.02 Allergic conjunctivitis ––– 9A60.0Y Other specified papillary conjunctivitis ––– 9A60.0Z Papillary conjunctivitis, unspecified ––– 9A60.30 Ulceration of conjunctiva ––– 9A60.31 Abscess of conjunctiva ––– 9A60.32 Conjunctivitis due to Koch-Weeks bacillus ––– 9A60.33 Acute epidemic conjunctivitis ––– 9A60.3Y Other specified mucopurulent conjunctivitis ––– 9A60.3Z Mucopurulent conjunctivitis, unspecified – 9A61 Certain specified disorders of conjunctiva –– 9A61.0 Pingueculae –– 9A61.1 Pterygium –– 9A61.2 Pseudopterygium of conjunctiva –– 9A61.3 Conjunctival scars –– 9A61.4 Conjunctival vascular disorders –– 9A61.5 Conjunctival or subconjunctival haemorrhage –– 9A61.6 Conjunctival or subconjunctival degenerations or deposits –– 9A61.Z Certain specified disorders of conjunctiva, unspecified ––– 9A61.40 Vascular abnormalities of conjunctiva ––– 9A61.4Y Other specified conjunctival vascular disorders ––– 9A61.4Z Conjunctival vascular disorders, unspecified – 9A62 Mucous membrane pemphigoid with ocular involvement – 9A6Y Other specified disorders of conjunctiva – 9A6Z Disorders of conjunctiva, unspecified – 9A70 Hereditary corneal dystrophies –– 9A70.0 Endothelial corneal dystrophy –– 9A70.Y Other specified hereditary corneal dystrophies –– 9A70.Z Hereditary corneal dystrophies, unspecified – 9A71 Infectious keratitis – 9A72 Traumatic keratitis – 9A73 Exposure keratitis – 9A74 Neurotrophic keratitis – 9A75 Autoimmune keratitis – 9A76 Corneal ulcer – 9A77 Corneal scars or opacities –– 9A77.0 Contact lens-associated corneal infiltrates –– 9A77.1 Adherent leukoma –– 9A77.Y Other specified corneal scars or opacities –– 9A77.Z Corneal scars or opacities, unspecified – 9A78 Certain specified disorders of cornea –– 9A78.0 Corneal neovascularization –– 9A78.1 Corneal pigmentations or deposits –– 9A78.2 Corneal oedema –– 9A78.3 Changes in corneal membranes –– 9A78.4 Corneal degeneration –– 9A78.5 Corneal deformities –– 9A78.6 Anaesthesia of cornea –– 9A78.7 Hypoesthesia of cornea –– 9A78.8 Recurrent erosion of cornea –– 9A78.9 Corneal abscess –– 9A78.A Sclerosing keratitis –– 9A78.Z Certain specified disorders of cornea, unspecified ––– 9A78.20 Bullous keratopathy ––– 9A78.21 Secondary corneal oedema ––– 9A78.2Y Other specified corneal oedema ––– 9A78.2Z Corneal oedema, unspecified ––– 9A78.50 Keratoconus ––– 9A78.51 Corneal staphyloma ––– 9A78.5Y Other specified corneal deformities ––– 9A78.5Z Corneal deformities, unspecified – 9A79 Keratoconjunctivitis sicca – 9A7Y Other specified disorders of the cornea – 9A7Z Disorders of the cornea, unspecified – 9A80 Hyphaema – 9A81 Parasites in the anterior chamber of the eye – 9A82 Cyst in the anterior chamber of the eye – 9A83 Flat anterior chamber hypotony of eye – 9A8Y Other specified disorders of the anterior chamber – 9A8Z Disorders of the anterior chamber, unspecified – 9A90 Degeneration of iris or ciliary body –– 9A90.0 Disorders of chamber angle –– 9A90.1 Degeneration of iris –– 9A90.2 Iris atrophy –– 9A90.Y Other specified degeneration of iris or ciliary body –– 9A90.Z Degeneration of iris or ciliary body, unspecified – 9A91 Cyst of iris or ciliary body – 9A92 Persistent pupillary membranes – 9A93 Adhesions or disruptions of iris or ciliary body – 9A94 Certain specified disorders of iris or ciliary body –– 9A94.0 Rubeosis of iris –– 9A94.1 Floppy iris syndrome –– 9A94.2 Plateau iris syndrome –– 9A94.Y Other disorders of iris and ciliary body – 9A96 Anterior uveitis –– 9A96.0 Anterior uveitis not associated with systemic conditions –– 9A96.1 Anterior uveitis associated with systemic conditions –– 9A96.2 Infection-associated anterior uveitis –– 9A96.3 Primary anterior uveitis –– 9A96.Y Other specified anterior uveitis –– 9A96.Z Anterior uveitis, unspecified – 9A9Y Other specified disorders of the anterior uvea – 9A9Z Disorders of the anterior uvea, unspecified – 9B00 Disorders of the afferent pupillary system –– 9B00.0 Relative afferent pupillary defects –– 9B00.1 Amaurotic pupillary reaction –– 9B00.2 Paradoxical pupillary reaction to light or darkness –– 9B00.3 Wernicke pupils –– 9B00.Y Other specified disorders of the afferent pupillary system –– 9B00.Z Disorders of the afferent pupillary system, unspecified – 9B01 Disorders of the efferent pupillary system –– 9B01.0 Physiologic anisocoria –– 9B01.1 Parasympathoparetic pupils –– 9B01.2 Pharmacologic inhibition of the parasympathetic pathway –– 9B01.3 Iris sphincter disorders –– 9B01.4 Pharmacologic parasympathicotonic pupils –– 9B01.5 Pharmacologic sympathoparetic pupils –– 9B01.6 Sympathotonic pupils –– 9B01.7 Episodic unilateral mydriasis –– 9B01.Y Other specified disorders of the efferent pupillary system –– 9B01.Z Disorders of the efferent pupillary system, unspecified – 9B02 Light-near dissociations –– 9B02.0 Argyll Robertson pupil –– 9B02.1 Pregeniculate light-near dissociations –– 9B02.2 Mesencephalic light-near dissociations –– 9B02.Y Other specified light-near dissociations –– 9B02.Z Light-near dissociations, unspecified – 9B0Y Other specified functional disorders of the pupil – 9B0Z Functional disorders of the pupil, unspecified – 9B10 Cataract –– 9B10.0 Age-related cataract –– 9B10.1 Infantile or juvenile cataract –– 9B10.2 Certain specified cataracts –– 9B10.Z Cataract, unspecified ––– 9B10.00 Coronary age-related cataract ––– 9B10.01 Punctate age-related cataract ––– 9B10.02 Mature age-related cataract ––– 9B10.0Y Other specified age-related cataract ––– 9B10.0Z Age-related cataract, unspecified ––– 9B10.10 Combined forms of infantile and juvenile cataract ––– 9B10.1Y Other specified infantile or juvenile cataract ––– 9B10.1Z Infantile or juvenile cataract, unspecified ––– 9B10.20 Traumatic cataract ––– 9B10.21 Diabetic cataract ––– 9B10.22 After-cataract ––– 9B10.23 Subcapsular glaucomatous flecks ––– 9B10.2Y Other specified cataracts – 9B11 Certain specified disorders of lens –– 9B11.0 Aphakia –– 9B11.1 Dislocation of lens –– 9B11.Y Other disorders of lens – 9B1Z Disorders of lens, unspecified 9B3Y Other specified disorders of the eyeball - anterior segment 9B3Z Disorders of the eyeball - anterior segment, unspecified – 9B50 Episcleritis – 9B51 Scleritis – 9B52 Scleral staphyloma – 9B5Y Other specified disorders of sclera – 9B5Z Disorders of sclera, unspecified – 9B60 Choroidal degeneration – 9B61 Choroidal dystrophy – 9B62 Chorioretinal scars – 9B63 Choroidal haemorrhage or rupture – 9B64 Choroidal detachment – 9B65 Choroiditis –– 9B65.0 Noninfectious posterior choroiditis –– 9B65.1 Infectious posterior choroiditis –– 9B65.2 Chorioretinal inflammation –– 9B65.Z Choroiditis, unspecified – 9B66 Intermediate choroiditis –– 9B66.0 Noninfectious intermediate choroiditis –– 9B66.1 Infectious intermediate choroiditis –– 9B66.Z Intermediate choroiditis, unspecified – 9B6Y Other specified disorders of the choroid – 9B6Z Disorders of the choroid, unspecified – 9B70 Inherited retinal dystrophies – 9B71 Retinopathy –– 9B71.0 Diabetic retinopathy –– 9B71.1 Hypertensive retinopathy –– 9B71.2 Radiation retinopathy –– 9B71.3 Retinopathy of prematurity –– 9B71.4 Paraneoplastic retinopathy –– 9B71.5 Autoimmune retinopathy –– 9B71.Y Other specified retinopathy –– 9B71.Z Retinopathy, unspecified ––– 9B71.00 Nonproliferative diabetic retinopathy ––– 9B71.01 Proliferative diabetic retinopathy ––– 9B71.02 Diabetic macular oedema ––– 9B71.0Z Diabetic retinopathy, unspecified ––– 9B71.40 Melanoma associated retinopathy ––– 9B71.4Y Other specified paraneoplastic retinopathy ––– 9B71.4Z Paraneoplastic retinopathy, unspecified – 9B72 Inflammatory diseases of the retina –– 9B72.0 Viral retinitis –– 9B72.Y Other specified inflammatory diseases of the retina –– 9B72.Z Inflammatory diseases of the retina, unspecified ––– 9B72.00 Cytomegaloviral retinitis ––– 9B72.01 HIV retinitis ––– 9B72.0Y Other specified viral retinitis ––– 9B72.0Z Viral retinitis, unspecified – 9B73 Retinal detachments or breaks –– 9B73.0 Retinal detachment with retinal break –– 9B73.1 Retinoschisis –– 9B73.2 Retinal cysts –– 9B73.3 Serous retinal detachment –– 9B73.4 Retinal breaks without detachment –– 9B73.Y Other specified retinal detachments or breaks –– 9B73.Z Retinal detachments or breaks, unspecified ––– 9B73.10 Adult retinoschisis ––– 9B73.11 Juvenile retinoschisis ––– 9B73.1Y Other specified retinoschisis ––– 9B73.1Z Retinoschisis, unspecified – 9B74 Retinal vascular occlusions –– 9B74.0 Retinal artery occlusions –– 9B74.1 Retinal venous occlusions –– 9B74.2 Combined retinal arterial and vein occlusion –– 9B74.Y Other specified retinal vascular occlusions –– 9B74.Z Retinal vascular occlusions, unspecified – 9B75 Macular disorders –– 9B75.0 Age-related macular degeneration –– 9B75.1 Non-traumatic macular hole –– 9B75.2 Central serous chorioretinopathy –– 9B75.3 Macular telangiectasia –– 9B75.Y Other specified macular disorders –– 9B75.Z Macular disorders, unspecified ––– 9B75.00 Early age-related macular degeneration ––– 9B75.01 Intermediate age-related macular degeneration ––– 9B75.03 Atrophic late-stage age-related macular degeneration ––– 9B75.04 Neovascular late-stage age-related macular degeneration ––– 9B75.0Y Other specified age-related macular degeneration ––– 9B75.0Z Age-related macular degeneration, unspecified – 9B76 Degenerative high myopia – 9B77 Eales disease – 9B78 Certain specified retinal disorders –– 9B78.0 Retinal vasculopathy and cerebral leukodystrophy –– 9B78.1 Background retinopathy and retinal vascular changes –– 9B78.2 Other proliferative retinopathy –– 9B78.3 Degeneration of macula or posterior pole –– 9B78.4 Peripheral retinal degeneration –– 9B78.5 Retinal haemorrhage –– 9B78.6 Separation of retinal layers –– 9B78.7 Retinal oedema –– 9B78.8 Retinal ischaemia –– 9B78.9 Retinal atrophy ––– 9B78.10 Changes in retinal vascular appearance ––– 9B78.11 Exudative retinopathy ––– 9B78.12 Retinal vasculitis ––– 9B78.13 Retinal telangiectasis ––– 9B78.1Y Other specified background retinopathy and retinal vascular changes ––– 9B78.1Z Background retinopathy and retinal vascular changes, unspecified ––– 9B78.30 Reticular pseudodrusen ––– 9B78.3Y Other specified degeneration of macula or posterior pole ––– 9B78.3Z Degeneration of macula or posterior pole, unspecified ––– 9B78.60 Serous detachment of retinal pigment epithelium ––– 9B78.61 Haemorrhagic detachment of retinal pigment epithelium ––– 9B78.6Y Other specified separation of retinal layers ––– 9B78.6Z Separation of retinal layers, unspecified – 9B7Y Other specified disorders of the retina – 9B7Z Disorders of the retina, unspecified – 9B80 Inherited vitreoretinal disorders – 9B81 Posterior vitreous detachment – 9B82 Vitreous prolapse – 9B83 Vitreous haemorrhage – 9B84 Vitreous opacities, membranes or strands – 9B8Y Other specified disorders of the vitreous body – 9B8Z Disorders of the vitreous body, unspecified 9C0Y Other specified disorders of the eyeball - posterior segment 9C0Z Disorders of the eyeball - posterior segment, unspecified 9C20 Panuveitis – 9C20.0 Noninfectious panuveitis – 9C20.1 Infectious panuveitis – 9C20.2 Purulent endophthalmitis – 9C20.Y Other specified panuveitis – 9C20.Z Panuveitis, unspecified 9C21 Endophthalmitis – 9C21.0 Sympathetic uveitis – 9C21.Y Other specified endophthalmitis – 9C21.Z Endophthalmitis, unspecified 9C22 Eyeball deformity – 9C22.0 Atrophia bulbi – 9C22.1 Phthisis bulbi – 9C22.Y Other specified eyeball deformity – 9C22.Z Eyeball deformity, unspecified 9C2Y Other specified disorders of the eyeball affecting both anterior and posterior segments 9C2Z Disorders of the eyeball affecting both anterior and posterior segments, unspecified 9C40 Disorder of the optic nerve – 9C40.0 Infectious optic neuropathy – 9C40.1 Optic neuritis – 9C40.2 Neuroretinitis – 9C40.3 Perineuritis of optic nerve – 9C40.4 Ischaemic optic neuropathy – 9C40.5 Compressive optic neuropathy – 9C40.6 Infiltrative optic neuropathy – 9C40.7 Traumatic optic neuropathy – 9C40.8 Hereditary optic neuropathy – 9C40.9 Glaucomatous optic neuropathy – 9C40.A Optic disc swelling – 9C40.B Optic atrophy – 9C40.Y Other specified disorder of the optic nerve – 9C40.Z Disorder of the optic nerve, unspecified –– 9C40.10 Retrobulbar neuritis –– 9C40.1Y Other specified optic neuritis –– 9C40.1Z Optic neuritis, unspecified –– 9C40.40 Anterior ischemic optic neuropathy –– 9C40.41 Posterior ischemic optic neuropathy –– 9C40.4Y Other specified ischaemic optic neuropathy –– 9C40.4Z Ischaemic optic neuropathy, unspecified –– 9C40.A0 Papilloedema –– 9C40.A1 Optic disc swelling associated with uveitis –– 9C40.AY Other specified optic disc swelling –– 9C40.AZ Optic disc swelling, unspecified –– 9C40.B0 Congenital optic atrophy –– 9C40.B1 Acquired optic atrophy –– 9C40.BZ Optic atrophy, unspecified 9C41 Disorder of optic chiasm 9C42 Disorder of post chiasmal visual pathways 9C43 Disorder of visual cortex 9C44 Disorder of higher visual centres 9C4Y Other specified disorders of the visual pathways or centres 9C4Z Disorders of the visual pathways or centres, unspecified 9C60 Glaucoma suspect 9C61 Glaucoma – 9C61.0 Primary open-angle glaucoma – 9C61.1 Primary angle closure and angle closure glaucoma – 9C61.2 Secondary open-angle glaucoma – 9C61.3 Secondary angle closure glaucoma – 9C61.4 Developmental glaucoma – 9C61.Z Glaucoma, unspecified –– 9C61.00 Normal tension glaucoma –– 9C61.01 Ocular hypertension –– 9C61.0Y Other specified primary open-angle glaucoma –– 9C61.0Z Primary open-angle glaucoma, unspecified –– 9C61.10 Primary angle closure suspect or anatomical narrow angle –– 9C61.11 Primary angle-closure –– 9C61.12 Primary angle closure glaucoma –– 9C61.13 Primary angle closure without pupillary block –– 9C61.14 Acute angle closure with pupillary block –– 9C61.15 Intermittent angle-closure –– 9C61.16 Chronic angle-closure –– 9C61.17 Condition after acute angle-closure glaucoma attack –– 9C61.1Y Other specified primary angle closure and angle closure glaucoma –– 9C61.1Z Primary angle closure and angle closure glaucoma, unspecified –– 9C61.20 Pseudoexfoliative open-angle glaucoma –– 9C61.21 Pigmentary open-angle glaucoma –– 9C61.22 Lens-induced secondary open-angle glaucoma –– 9C61.23 Glaucoma associated with intraocular haemorrhage –– 9C61.24 Glaucoma due to eye inflammation –– 9C61.25 Glaucomato-cyclitic crisis –– 9C61.26 Secondary open-angle glaucoma due to parasitic eye disease –– 9C61.27 Glaucoma due to intraocular tumours –– 9C61.28 Glaucoma associated with retinal detachment –– 9C61.29 Glaucoma due to eye trauma –– 9C61.2A Glaucoma due to drugs –– 9C61.2B Glaucoma caused by increased episcleral venous pressure –– 9C61.2C Secondary glaucoma due to extra-ocular mass –– 9C61.2Y Other specified secondary open-angle glaucoma –– 9C61.2Z Secondary open-angle glaucoma, unspecified –– 9C61.30 Secondary angle closure glaucoma with pupillary block –– 9C61.31 Secondary angle closure glaucoma without pupillary block –– 9C61.32 Neovascular secondary angle closure glaucoma –– 9C61.33 Secondary angle closure glaucoma due to endothelial overgrowth –– 9C61.34 Secondary angle closure glaucoma due to epithelial ingrowth –– 9C61.35 Ciliary block glaucoma –– 9C61.36 Secondary angle closure glaucoma due to other anterior displacement of the lens-iris diaphragm –– 9C61.3Y Other specified secondary angle closure glaucoma –– 9C61.3Z Secondary angle closure glaucoma, unspecified –– 9C61.40 Primary congenital glaucoma –– 9C61.41 Primary infantile glaucoma –– 9C61.42 Secondary childhood glaucoma –– 9C61.4Y Other specified developmental glaucoma –– 9C61.4Z Developmental glaucoma, unspecified 9C6Y Other specified glaucoma or glaucoma suspect 9C6Z Glaucoma or glaucoma suspect, unspecified 9C80 Non paralytic strabismus – 9C80.0 Esotropia – 9C80.1 Exotropia – 9C80.2 Vertical or torsional strabismus – 9C80.3 Intermittent strabismus – 9C80.4 Heterophoria – 9C80.5 Mechanical strabismus – 9C80.Y Other specified non paralytic strabismus – 9C80.Z Non paralytic strabismus, unspecified –– 9C80.30 Intermittent divergent exotropia –– 9C80.31 Intermittent convergent esotropia –– 9C80.3Y Other specified intermittent strabismus –– 9C80.3Z Intermittent strabismus, unspecified 9C81 Ocular motor nerve palsies – 9C81.0 Third nerve palsy – 9C81.1 Fourth nerve palsy – 9C81.2 Sixth nerve palsy – 9C81.3 Total external ophthalmoplegia – 9C81.4 Cavernous sinus syndromes – 9C81.Y Palsy of other specified ocular motor nerve – 9C81.Z Palsy of unspecified ocular motor nerve –– 9C81.00 External bilateral paralysis of oculomotor nerve –– 9C81.0Y Other specified third nerve palsy –– 9C81.0Z Third nerve palsy, unspecified 9C82 Disorders of extraocular muscles – 9C82.0 Progressive external ophthalmoplegia – 9C82.1 Muscular dystrophy affecting extraocular muscle – 9C82.2 Congenital cranial dysinnervation syndrome – 9C82.3 Restrictive ophthalmopathy – 9C82.4 Oculomotor apraxia – 9C82.Y Other specified disorders of extraocular muscles – 9C82.Z Disorders of extraocular muscles, unspecified 9C83 Disorders of binocular movement – 9C83.0 Palsy of conjugate gaze – 9C83.1 Spasm of conjugate gaze – 9C83.2 Convergence insufficiency – 9C83.3 Convergence excess – 9C83.4 Spasm of the near reflex – 9C83.5 Internuclear ophthalmoplegia – 9C83.6 Anomalies of divergence or deviation of eye movement – 9C83.Y Other specified disorders of binocular movement – 9C83.Z Disorders of binocular movement, unspecified –– 9C83.00 Horizontal gaze palsy –– 9C83.01 Vertical gaze palsy –– 9C83.02 Monocular elevator palsy –– 9C83.0Y Other specified palsy of conjugate gaze –– 9C83.0Z Palsy of conjugate gaze, unspecified –– 9C83.10 Horizontal conjugate gaze deviation –– 9C83.11 Upward gaze deviation –– 9C83.12 Downward gaze deviation –– 9C83.13 Oculogyric crisis –– 9C83.1Y Other specified spasm of conjugate gaze –– 9C83.1Z Spasm of conjugate gaze, unspecified –– 9C83.60 Divergence insufficiency –– 9C83.61 Divergence paralysis –– 9C83.62 Divergence excess –– 9C83.63 Synergistic divergence –– 9C83.64 Skew deviation –– 9C83.65 Ocular tilt reaction –– 9C83.66 Alternating skew deviation –– 9C83.67 Dissociative vertical divergence –– 9C83.6Y Other specified anomalies of divergence or deviation of eye movement –– 9C83.6Z Anomalies of divergence or deviation of eye movement, unspecified 9C84 Nystagmus – 9C84.0 Physiological nystagmus – 9C84.1 Congenital forms of nystagmus – 9C84.2 Vestibular nystagmus – 9C84.3 Seesaw nystagmus – 9C84.4 Gaze-evoked nystagmus – 9C84.5 Nystagmus occurring in visual system disorders – 9C84.6 Eyelid nystagmus – 9C84.Y Other specified nystagmus – 9C84.Z Nystagmus, unspecified –– 9C84.20 Downbeat nystagmus –– 9C84.21 Upbeat nystagmus –– 9C84.22 Torsional nystagmus –– 9C84.23 Perverted nystagmus –– 9C84.2Y Other specified vestibular nystagmus –– 9C84.2Z Vestibular nystagmus, unspecified –– 9C84.50 Visual deprivation nystagmus –– 9C84.51 Divergence nystagmus –– 9C84.52 Convergence-retraction nystagmus –– 9C84.5Y Other specified nystagmus occurring in visual system disorders –– 9C84.5Z Nystagmus occurring in visual system disorders, unspecified 9C85 Certain specified irregular eye movements – 9C85.0 Anomalies of saccadic eye movements – 9C85.1 Anomalies of smooth pursuit movements – 9C85.2 Nonorganic eye movement disorders – 9C85.Y Other specified irregular eye movements – 9C85.Z Irregular eye movements, unspecified –– 9C85.00 Disorders of the saccadic pulse –– 9C85.01 Disorders of the saccadic step –– 9C85.02 Inappropriate saccades –– 9C85.0Y Other specified anomalies of saccadic eye movements –– 9C85.0Z Anomalies of saccadic eye movements, unspecified 9C8Y Other specified strabismus or ocular motility disorders 9C8Z Strabismus or ocular motility disorders, unspecified 9D00 Disorders of refraction – 9D00.0 Myopia – 9D00.1 Hypermetropia – 9D00.2 Astigmatism – 9D00.3 Presbyopia – 9D00.4 Anisometropia – 9D00.5 Aniseikonia – 9D00.6 Transient refractive change – 9D00.Y Other specified disorders of refraction – 9D00.Z Disorders of refraction, unspecified 9D01 Disorders of accommodation – 9D01.0 Internal ophthalmoplegia – 9D01.1 Paresis of accommodation – 9D01.2 Spasm of accommodation – 9D01.Y Other specified disorders of accommodation – 9D01.Z Disorders of accommodation, unspecified 9D0Y Other specified disorders of refraction or accommodation 9D0Z Disorders of refraction or accommodation, unspecified 9D20 Bullous aphakic keratopathy following cataract surgery 9D21 Cataract lens fragments in eye following cataract surgery 9D22 Chorioretinal scars after surgery for detachment 9D23 Conjunctival blebitis after glaucoma surgery 9D24 Complications with glaucoma drainage devices 9D25 Glaucoma due to ocular surgery or laser 9D41 Impairment of visual field 9D42 Patterns of visual field impairment – 9D42.0 Visual field loss, pattern not specified – 9D42.2 Peripheral field deficit – 9D42.3 Hemianopic or quadrantic loss – 9D42.4 Central scotoma – 9D42.5 Para-central scotoma – 9D42.6 Homonymous hemianopia or quadrant anopia – 9D42.7 Heteronymous hemianopia or quadrant anopia – 9D42.8 Visual field loss, other specified forms – 9D42.Y Other specified patterns of visual field impairment – 9D42.Z Patterns of visual field impairment, unspecified –– 9D42.20 Enlarged blind spot –– 9D42.21 Arcuate scotoma –– 9D42.22 Nasal step –– 9D42.23 Ring scotoma –– 9D42.24 Isolated peripheral scotoma –– 9D42.2Y Other specified peripheral field deficit –– 9D42.2Z Peripheral field deficit, unspecified –– 9D42.60 Right hemi-field homonymous hemianopia or quadrant anopia –– 9D42.61 Left hemi-field homonymous hemianopia or quadrant anopia –– 9D42.6Y Other specified homonymous hemianopia or quadrant anopia –– 9D42.6Z Homonymous hemianopia or quadrant anopia, unspecified –– 9D42.70 Bi-nasal defects heteronymous hemianopia or quadrant anopia –– 9D42.71 Bi-temporal defects heteronymous hemianopia or quadrant anopia –– 9D42.7Y Other specified heteronymous hemianopia or quadrant anopia –– 9D42.7Z Heteronymous hemianopia or quadrant anopia, unspecified 9D43 Impairment of contrast vision 9D44 Impairment of colour vision 9D45 Impairment of light sensitivity 9D46 Impairment of binocular functions – 9D50 Visual discomfort – 9D51 Transient visual loss – 9D52 Hemifield losses – 9D53 Entoptic phenomena – 9D54 Visual illusions – 9D55 Nonorganic visual loss – 9D56 Visual release hallucinations – 9D5Y Other specified subjective visual experiences – 9D5Z Subjective visual experiences, unspecified 9D7Y Other specified impairment of visual functions 9D7Z Impairment of visual functions, unspecified 9D90 Vision impairment including blindness – 9D90.1 Mild vision impairment – 9D90.2 Moderate vision impairment – 9D90.3 Severe vision impairment – 9D90.6 Blindness – 9D90.7 Near vision impairment 9D92 Specific vision dysfunctions 9D93 Complex vision-related dysfunctions 9D94 Impairment of presenting visual acuity 9D95 Impairment of best corrected visual acuity 9D96 Impairment of uncorrected visual acuity 9D9Y Other specified vision impairment 9D9Z Vision impairment, unspecified 9E1Y Other specified diseases of the visual system 9E1Z Diseases of the visual system, unspecified – AA00 Abscess of external ear – AA01 Cellulitis of external ear – AA02 Malignant otitis externa – AA03 Otomycosis – AA04 Perichondritis of external ear – AA0Y Other specified infectious diseases of external ear – AA0Z Infectious diseases of external ear, unspecified –– AA10 Seborrhoeic otitis externa –– AA11 Acute noninfectious otitis externa –– AA12 Chondrodermatitis nodularis –– AA13 Chronic otitis externa –– AA1Y Other specified noninfectious inflammation of external ear –– AA1Z Noninfectious inflammation of external ear, unspecified – AA3Y Other specified otitis externa – AA3Z Otitis externa, unspecified – AA40 Acquired deformity of external auditory canal –– AA40.0 Exostosis of external auditory canal –– AA40.1 Acquired stenosis of external auditory canal –– AA40.2 Cholesteatoma of external auditory canal –– AA40.Y Other specified acquired deformity of external auditory canal – AA41 Acquired deformity of pinna –– AA41.0 Cauliflower ear –– AA41.Y Other specified acquired deformity of pinna – AA42 Impacted cerumen – AA4Y Other specified noninflammatory disorders of the external ear – AA4Z Noninflammatory disorders of the external ear, unspecified AA6Z Diseases of external ear, unspecified –– AA80 Acute serous or mucoid otitis media –– AA81 Acute nonserous nonsuppurative otitis media –– AA82 Chronic serous or mucoid otitis media –– AA83 Noninfected otitis media with effusion –– AA8Z Nonsuppurative otitis media, unspecified –– AA90 Acute suppurative otitis media –– AA91 Chronic suppurative otitis media ––– AA91.0 Chronic tubotympanic suppurative otitis media ––– AA91.1 Chronic atticoantral suppurative otitis media ––– AA91.2 Other chronic suppurative otitis media ––– AA91.Z Chronic suppurative otitis media, unspecified –– AA9Z Suppurative otitis media, unspecified whether acute or chronic – AB00 Acute otitis media – AB01 Chronic otitis media – AB0Y Other specified otitis media – AB0Z Otitis media, unspecified AB10 Disorders of Eustachian tube – AB10.0 Diverticulum of Eustachian tube – AB10.1 Patulous Eustachian tube – AB10.2 Eustachian salpingitis – AB10.3 Obstruction of Eustachian tube – AB10.Y Other specified disorders of Eustachian tube – AB10.Z Disorders of Eustachian tube, unspecified AB11 Mastoiditis or related conditions – AB11.0 Acute mastoiditis – AB11.1 Chronic mastoiditis – AB11.2 Petrositis – AB11.3 Mastoiditis, not elsewhere classified – AB11.Y Other specified mastoiditis or related conditions AB12 Cholesteatoma of middle ear AB13 Perforation of tympanic membrane – AB13.0 Central perforation of tympanic membrane – AB13.1 Attic perforation of tympanic membrane – AB13.2 Other marginal perforations of tympanic membrane – AB13.Y Other specified perforation of tympanic membrane – AB13.Z Perforation of tympanic membrane, unspecified AB14 Acute myringitis AB15 Chronic myringitis AB16 Tympanosclerosis AB17 Adhesive middle ear disease AB18 Discontinuity or dislocation of ear ossicles AB19 Acquired abnormalities of ear ossicles not related to discontinuity or dislocation AB1A Polyp of middle ear – AB1A.0 Aural polyp – AB1A.Y Other specified polyp of middle ear – AB1A.Z Polyp of middle ear, unspecified AB1B Middle ear cicatrix AB1Y Other specified diseases of middle ear or mastoid AB1Z Diseases of middle ear or mastoid, unspecified AB30 Acute vestibular syndrome – AB30.0 Vestibular neuritis – AB30.1 Labyrinthitis – AB30.Y Other specified acute vestibular syndrome – AB30.Z Acute vestibular syndrome, unspecified AB31 Episodic vestibular syndrome – AB31.0 Meniere disease – AB31.1 Vestibular migraine – AB31.2 Benign positional paroxysmal vertigo – AB31.3 Superior canal dehiscence syndrome – AB31.4 Disembarkment syndrome – AB31.5 Autoimmune inner ear disease – AB31.6 Vestibular paroxysmia – AB31.7 Vertiginous syndromes – AB31.Y Other specified episodic vestibular syndrome – AB31.Z Episodic vestibular syndrome, unspecified AB32 Chronic vestibular syndrome – AB32.0 Persistent Postural-Perceptual Dizziness – AB32.1 Chronic unilateral idiopathic vestibulopathy – AB32.2 Persistent unilateral vestibulopathy after vestibular neuronitis – AB32.3 Unilateral vestibulopathy due to schwannoma – AB32.4 Unilateral vestibulopathy after medical intervention – AB32.5 Chronic bilateral vestibulopathy – AB32.Y Other specified chronic vestibular syndrome – AB32.Z Chronic vestibular syndrome, unspecified AB33 Otosclerosis AB34 Disorders of vestibular function – AB34.0 Idiopathic bilateral vestibulopathy – AB34.1 Other peripheral vertigo – AB34.Y Other specified disorders of vestibular function – AB34.Z Disorders of vestibular function, unspecified AB35 Labyrinthine fistula AB36 Labyrinthine dysfunction AB37 Noise effects on inner ear AB3Y Other specified diseases of inner ear AB3Z Diseases of inner ear, unspecified AB50 Congenital hearing impairment – AB50.0 Congenital conductive hearing loss – AB50.1 Congenital sensorineural hearing loss – AB50.2 Congenital mixed conductive and sensorineural hearing loss – AB50.Y Other specified congenital hearing impairment – AB50.Z Congenital hearing impairment, unspecified AB51 Acquired hearing impairment – AB51.0 Acquired conductive hearing loss – AB51.1 Acquired sensorineural hearing loss – AB51.2 Acquired mixed conductive and sensorineural hearing loss – AB51.Y Other specified acquired hearing impairment – AB51.Z Acquired hearing impairment, unspecified AB52 Deafness not otherwise specified AB53 Ototoxic hearing loss AB54 Presbycusis AB55 Sudden idiopathic hearing loss AB56 Hereditary hearing loss AB57 Auditory synaptopathy or neuropathy AB5Y Other specified disorders with hearing impairment AB5Z Disorders with hearing impairment, unspecified AB70 Otalgia or effusion of ear – AB70.0 Otorrhoea – AB70.1 Otorrhagia – AB70.2 Otalgia AB71 Degenerative or vascular disorders of ear AB72 Disorders of acoustic nerve – AB72.0 Acoustic neuritis – AB72.Y Other specified disorders of acoustic nerve – AB72.Z Disorders of acoustic nerve, unspecified AB73 Atrophy ear AB7Y Other specified disorders of ear, not elsewhere classified AB90 Recurrent cholesteatoma of postmastoidectomy cavity AB91 Mucosal cyst of postmastoidectomy cavity AB92 Granulation of postmastoidectomy cavity AB93 Chronic inflammation of postmastoidectomy cavity AC0Y Other specified diseases of the ear or mastoid process AC0Z Diseases of the ear or mastoid process, unspecified – FA00 Osteoarthritis of hip –– FA00.0 Primary osteoarthritis of hip –– FA00.1 Post traumatic osteoarthritis of hip –– FA00.2 Other secondary osteoarthritis of hip –– FA00.Z Osteoarthritis of hip, unspecified – FA01 Osteoarthritis of knee –– FA01.0 Primary osteoarthritis of knee –– FA01.1 Post traumatic osteoarthritis of knee –– FA01.2 Other secondary osteoarthritis of knee –– FA01.Z Osteoarthritis of knee, unspecified – FA02 Osteoarthritis of wrist or hand –– FA02.0 Primary osteoarthritis of wrist or hand –– FA02.1 Post traumatic osteoarthritis of wrist or hand –– FA02.2 Other secondary osteoarthritis of wrist or hand –– FA02.Z Osteoarthritis of wrist or hand, unspecified – FA03 Osteoarthritis of other specified joint –– FA03.0 Primary osteoarthritis of other specified joint –– FA03.1 Post traumatic osteoarthritis of other specified joint –– FA03.2 Other secondary osteoarthritis of other specified joint –– FA03.Z Osteoarthritis of other specified joint, unspecified – FA04 Oligoosteoarthritis – FA05 Polyosteoarthritis – FA0Z Osteoarthritis, unspecified – FA10 Direct infections of joint –– FA10.0 Bacterial infection of joint –– FA10.1 Viral infection of joint –– FA10.2 Fungal infection of joint –– FA10.Z Direct infections of joint, unspecified – FA11 Reactive arthropathies –– FA11.0 Arthropathy following intestinal bypass –– FA11.1 Arthropathy following vaccination –– FA11.2 Arthropathy following genitourinary infection –– FA11.Y Other specified reactive arthropathies –– FA11.Z Reactive arthropathies, unspecified – FA12 Postinfectious arthropathies –– FA12.0 Bacterial postinfectious arthropathy –– FA12.1 Viral postinfectious arthropathies –– FA12.2 Fungal postinfectious arthropathies –– FA12.3 Parasitic postinfectious arthropathies –– FA12.Y Other specified postinfectious arthropathies –– FA12.Z Postinfectious arthropathies, unspecified – FA13 Infectious spondyloarthritis – FA1Y Other specified infection related arthropathies – FA1Z Infection related arthropathies, unspecified – FA20 Rheumatoid arthritis –– FA20.0 Seropositive rheumatoid arthritis –– FA20.1 Seronegative rheumatoid arthritis –– FA20.Z Rheumatoid arthritis, serology unspecified – FA21 Psoriatic arthritis –– FA21.0 Psoriatic spondyloarthritis –– FA21.Y Other specified psoriatic arthritis –– FA21.Z Psoriatic arthritis, unspecified – FA22 Polymyalgia rheumatica – FA23 Adult-onset Still disease – FA24 Juvenile idiopathic arthritis –– FA24.0 Juvenile idiopathic oligoarthritis –– FA24.1 Juvenile idiopathic polyarthritis –– FA24.2 Juvenile psoriatic arthritis –– FA24.3 Juvenile enthesitis related arthritis –– FA24.4 Juvenile systemic arthritis –– FA24.Y Other specified juvenile idiopathic arthritis –– FA24.Z Juvenile idiopathic arthritis, unspecified ––– FA24.00 Juvenile idiopathic oligoarthritis, onset persistent ––– FA24.01 Juvenile idiopathic oligoarthritis, onset extended ––– FA24.0Z Juvenile idiopathic oligoarthritis, onset unspecified – FA25 Gout –– FA25.0 Primary gout –– FA25.1 Secondary gout –– FA25.2 Gout without specification whether primary or secondary ––– FA25.10 Lead-induced gout ––– FA25.11 Drug-induced gout ––– FA25.12 Gouty arthropathy due to enzyme defects or other inherited disorders ––– FA25.1Y Other specified secondary gout ––– FA25.1Z Secondary gout, unspecified ––– FA25.20 Tophaceous gout ––– FA25.2Y Other specified gout without specification whether primary or secondary ––– FA25.2Z Gout, unspecified – FA26 Certain specified crystal arthropathies –– FA26.0 Calcium pyrophosphate dehydrate deposition disease –– FA26.1 Hydroxyapatite deposition disease –– FA26.2 Chondrocalcinosis –– FA26.Y Other specified crystal arthropathies –– FA26.Z Crystal arthropathies, unspecified – FA27 Certain specified inflammatory arthropathies –– FA27.0 Kashin-Beck disease –– FA27.1 Pigmented villonodular synovitis –– FA27.2 Palindromic rheumatism –– FA27.3 Transient synovitis –– FA27.4 Intermittent hydrarthrosis –– FA27.Y Other specified inflammatory arthropathies – FA2Z Inflammatory arthropathies, unspecified – FA30 Acquired deformities of fingers or toes –– FA30.0 Acquired hallux valgus –– FA30.1 Hallux rigidus –– FA30.2 Acquired hammer toe –– FA30.Y Other specified acquired deformities of fingers or toes –– FA30.Z Acquired deformities of fingers or toes, unspecified – FA31 Other acquired deformities of limbs –– FA31.0 Valgus deformity, not elsewhere classified –– FA31.1 Varus deformity, not elsewhere classified –– FA31.2 Flexion deformity –– FA31.3 Acquired wrist drop –– FA31.4 Acquired foot drop –– FA31.5 Acquired pes planus –– FA31.6 Acquired clawhand or clubhand –– FA31.7 Acquired clawfoot or clubfoot –– FA31.8 Acquired unequal limb length –– FA31.Y Other specified acquired deformities of limbs –– FA31.Z Acquired deformities of limbs, unspecified – FA32 Disorders of patella –– FA32.0 Recurrent instability of patella –– FA32.1 Patellofemoral disorders –– FA32.Y Other specified disorders of patella –– FA32.Z Disorders of patella, unspecified – FA33 Internal derangement of knee –– FA33.0 Cystic meniscus –– FA33.1 Discoid meniscus –– FA33.2 Derangement of meniscus due to old tear or injury –– FA33.3 Loose body in knee –– FA33.4 Chronic instability of knee –– FA33.Y Other specified internal derangement of knee –– FA33.Z Internal derangement of knee, unspecified ––– FA33.40 Chronic instability of knee, medial collateral ligament or other or unspecified part of medial meniscus ––– FA33.4Y Other specified chronic instability of knee ––– FA33.4Z Chronic instability of knee, unspecified – FA34 Certain specified joint derangements –– FA34.0 Loose body in joint –– FA34.1 Disorder of ligament –– FA34.2 Recurrent instability of joint –– FA34.3 Contracture of joint –– FA34.4 Ankylosis of joint –– FA34.5 Impingement syndrome of hip –– FA34.Y Other joint derangements – FA35 Wear of articular bearing surface of joint prosthesis –– FA35.0 Wear of articular bearing surface of joint prosthesis of hip –– FA35.1 Wear of articular bearing surface of joint prosthesis of knee –– FA35.2 Wear of articular bearing surface of joint prosthesis of other joint –– FA35.Z Wear of articular bearing surface of joint prosthesis of unspecified joint – FA36 Effusion of joint –– FA36.0 Effusion of joint containing blood –– FA36.Y Other specified effusion of joint –– FA36.Z Effusion of joint, unspecified – FA37 Certain joint disorders, not elsewhere classified –– FA37.0 Osteophyte –– FA37.Y Other specified certain joint disorders, not elsewhere classified –– FA37.Z Certain joint disorders, not elsewhere classified, unspecified – FA38 Arthropathy in diseases classified elsewhere –– FA38.0 Diabetic arthropathy –– FA38.1 Neuropathic arthropathy –– FA38.2 Arthropathy in hypersensitivity reactions classified elsewhere –– FA38.3 Haemophilic arthropathy –– FA38.Y Other specified arthropathy in diseases classified elsewhere –– FA38.Z Unspecified arthropathy in diseases classified elsewhere ––– FA38.10 Diabetic Charcot arthropathy ––– FA38.1Y Other specified neuropathic arthropathy ––– FA38.1Z Neuropathic arthropathy, unspecified – FA3Z Unspecified joint disorders and deformities of limbs FA5Y Other specified arthropathies FA5Z Arthropathies, unspecified – FA70 Spinal deformities –– FA70.0 Kyphosis –– FA70.1 Scoliosis –– FA70.2 Lordosis –– FA70.Z Spinal deformities, unspecified – FA71 Torticollis – FA72 Disorders of vertebra –– FA72.0 Ankylosing hyperostosis –– FA72.1 Kissing spine –– FA72.2 Traumatic spondylopathy –– FA72.3 Fatigue fracture of vertebra –– FA72.4 Collapsed vertebra, not elsewhere classified –– FA72.Y Other specified disorders of vertebra –– FA72.Z Disorders of vertebra, unspecified – FA7Y Other specified structural disorders of spine – FA7Z Structural disorders of spine, unspecified – FA80 Intervertebral disc degeneration –– FA80.0 Intervertebral disc degeneration of cervical spine without prolapsed disc –– FA80.1 Intervertebral disc degeneration of cervical spine with prolapsed disc –– FA80.2 Intervertebral disc degeneration of cervical spine with bony spur at the vertebra –– FA80.3 Intervertebral disc degeneration of cervical spine with nervous system involvement –– FA80.4 Intervertebral disc degeneration of thoracic spine without prolapsed disc –– FA80.5 Intervertebral disc degeneration of thoracic spine with prolapsed disc –– FA80.6 Intervertebral disc degeneration of thoracic spine with bony spur at the vertebra –– FA80.7 Intervertebral disc degeneration of thoracic spine with nervous system involvement –– FA80.8 Intervertebral disc degeneration of lumbar spine without prolapsed disc –– FA80.9 Intervertebral disc degeneration of lumbar spine with prolapsed disc –– FA80.A Intervertebral disc degeneration of lumbar spine with bony spur at the vertebra –– FA80.B Intervertebral disc degeneration of lumbar spine with nervous system involvement –– FA80.Y Other specified intervertebral disc degeneration –– FA80.Z Intervertebral disc degeneration, unspecified – FA81 Spondylolysis –– FA81.0 Spondylolysis with slippage –– FA81.1 Spondylolysis without slippage –– FA81.Z Spondylolysis, unspecified – FA82 Spinal stenosis – FA83 Ossification of spinal ligaments – FA84 Spondylolisthesis –– FA84.0 Spondylolisthesis with pars defect –– FA84.1 Spondylolisthesis without pars defect –– FA84.Z Spondylolisthesis, unspecified – FA85 Spinal endplate defects –– FA85.0 Spinal epiphysiopathy with no determinant –– FA85.1 Spinal epiphysiopathy with determinants –– FA85.Y Other specified spinal endplate defects –– FA85.Z Spinal endplate defects, unspecified ––– FA85.10 Localised central endplate defect ––– FA85.11 Multiple anterior endplate defect ––– FA85.12 Separation of ring apophysis ––– FA85.1Y Other specified spinal epiphysiopathy with determinants ––– FA85.1Z Spinal epiphysiopathy with determinants, unspecified – FA8Y Other specified degenerative condition of spine – FA8Z Degenerative condition of spine, unspecified – FA90 Infection of vertebra –– FA90.0 Infection of vertebra with no determinant –– FA90.1 Infection of vertebra with determinants –– FA90.Y Other specified infection of vertebra –– FA90.Z Infection of vertebra, unspecified – FA91 Infection of intervertebral disc – FA92 Inflammatory spondyloarthritis –– FA92.0 Axial spondyloarthritis –– FA92.1 Peripheral spondyloarthritis –– FA92.Y Other specified inflammatory spondyloarthritis –– FA92.Z Inflammatory spondyloarthritis, unspecified ––– FA92.00 Spinal enthesitis ––– FA92.01 Sacroiliitis, not elsewhere classified ––– FA92.0Y Other specified axial spondyloarthritis ––– FA92.0Z Axial spondyloarthritis, unspecified – FA9Y Other specified inflammation of spine – FA9Z Inflammation of spine, unspecified – FB00 Ankylosis of spinal joint – FB0Y Other specified spondylopathies – FB0Z Spondylopathies, unspecified FB10 Spinal instabilities FB1Y Other specified conditions associated with the spine FB1Z Conditions associated with the spine, unspecified – FB30 Infectious myositis – FB31 Calcification or ossification of muscle –– FB31.0 Progressive osseous heteroplasia –– FB31.1 Fibrodysplasia ossificans progressiva –– FB31.Y Other specified calcification or ossification of muscle –– FB31.Z Calcification or ossification of muscle, unspecified – FB32 Certain specified disorders of muscle –– FB32.0 Diastasis of muscle –– FB32.1 Spontaneous rupture of muscle –– FB32.2 Ischaemic infarction of muscle –– FB32.3 Immobility syndrome –– FB32.4 Contracture of muscle –– FB32.5 Muscle strain or sprain –– FB32.Y Other specified disorders of muscles ––– FB32.20 Idiopathic rhabdomyolysis ––– FB32.2Y Other specified ischaemic infarction of muscle ––– FB32.2Z Ischaemic infarction of muscle, unspecified – FB33 Secondary disorders of muscle – FB3Z Disorders of muscles, unspecified – FB40 Tenosynovitis –– FB40.0 Infectious tenosynovitis –– FB40.1 Plantar fasciitis –– FB40.2 Posterior tibial tendonitis –– FB40.3 Calcific tendinitis –– FB40.4 Trigger finger –– FB40.5 Radial styloid tenosynovitis –– FB40.Y Other specified tenosynovitis –– FB40.Z Tenosynovitis, unspecified – FB41 Spontaneous rupture of synovium or tendon –– FB41.0 Spontaneous rupture of popliteal cyst –– FB41.1 Spontaneous rupture of synovium –– FB41.2 Spontaneous rupture of tendon –– FB41.Y Other specified spontaneous rupture of synovium or tendon –– FB41.Z Spontaneous rupture of synovium or tendon, unspecified – FB42 Certain specified disorders of synovium or tendon –– FB42.0 Acquired short Achilles tendon –– FB42.1 Contracture of tendon sheath –– FB42.2 Ganglion –– FB42.3 Synovial hypertrophy, not elsewhere classified – FB43 Secondary disorders of synovium or tendon – FB4Y Other specified disorders of synovium or tendon – FB4Z Disorders of synovium or tendon, unspecified – FB50 Bursitis –– FB50.0 Infectious bursitis –– FB50.1 Bursitis related to use, overuse or pressure –– FB50.2 Synovial cyst of popliteal space –– FB50.3 Calcium deposit in bursa –– FB50.Y Other specified bursitis –– FB50.Z Bursitis, unspecified – FB51 Fibroblastic disorders –– FB51.0 Palmar fascial fibromatosis –– FB51.1 Knuckle pads –– FB51.2 Fasciitis and fibromatosis –– FB51.3 Fibroblastic rheumatism –– FB51.4 Retroperitoneal fibrosis –– FB51.Y Other specified fibroblastic disorders –– FB51.Z Fibroblastic disorders, unspecified ––– FB51.40 Primary retroperitoneal fibrosis ––– FB51.4Y Other specified retroperitoneal fibrosis ––– FB51.4Z Retroperitoneal fibrosis, unspecified – FB52 Soft tissue disorders in diseases classified elsewhere – FB53 Shoulder lesions –– FB53.0 Adhesive capsulitis of shoulder –– FB53.1 Rotator cuff syndrome –– FB53.2 Impingement syndrome of shoulder –– FB53.Y Other specified shoulder lesions –– FB53.Z Shoulder lesions, unspecified – FB54 Enthesopathies of lower limb –– FB54.0 Iliac crest spur –– FB54.1 Iliotibial band syndrome –– FB54.2 Tibial collateral bursitis –– FB54.3 Calcaneal spur –– FB54.4 Metatarsalgia –– FB54.Y Other specified enthesopathies of lower limb –– FB54.Z Enthesopathies of lower limb, unspecified – FB55 Certain specified enthesopathies –– FB55.0 Medial epicondylitis of elbow –– FB55.1 Lateral epicondylitis of elbow –– FB55.2 Periarthritis of wrist –– FB55.Z Enthesopathies, unspecified – FB56 Specified soft tissue disorders, not elsewhere classified –– FB56.0 Foreign body granuloma of soft tissue, not elsewhere classified –– FB56.1 Residual foreign body in soft tissue –– FB56.2 Myalgia –– FB56.3 Hypertrophy of infrapatellar fat pad –– FB56.4 Pain in limb –– FB56.6 Other specified soft tissue disorders FB6Z Soft tissue disorders, unspecified FB80 Certain specified disorders of bone density or structure – FB80.0 Fibrous dysplasia of bone – FB80.1 Skeletal fluorosis – FB80.2 Osteitis condensans – FB80.3 Hyperostosis of skull – FB80.4 Osteosclerosis – FB80.5 Solitary bone cyst – FB80.6 Aneurysmal bone cyst – FB80.7 Malunion of fracture – FB80.8 Nonunion of fracture – FB80.9 Delayed union of fracture – FB80.A Stress fracture, not elsewhere classified – FB80.B Pathological fracture – FB80.Y Other specified disorders of bone density and structure – FB80.Z Disorder of bone density and structure, unspecified FB81 Osteonecrosis – FB81.0 Idiopathic aseptic osteonecrosis – FB81.1 Osteonecrosis due to dialysis – FB81.2 Drug-induced osteonecrosis – FB81.3 Osteonecrosis due to trauma – FB81.4 Osteonecrosis due to haemoglobinopathy – FB81.5 Osteonecrosis due to ionizing radiation – FB81.6 Alcohol induced osteonecrosis – FB81.Y Other specified osteonecrosis – FB81.Z Osteonecrosis, unspecified FB82 Chondropathies – FB82.0 Chondromalacia – FB82.1 Osteochondrosis or osteochondritis dissecans – FB82.2 Slipped upper femoral epiphysis – FB82.3 Relapsing polychondritis – FB82.Y Other specified chondropathies – FB82.Z Chondropathies, unspecified –– FB82.00 Chondromalacia patellae –– FB82.0Y Other specified chondromalacia –– FB82.0Z Chondromalacia, unspecified FB83 Low bone mass disorders – FB83.0 Osteopenia – FB83.1 Osteoporosis – FB83.2 Adult osteomalacia –– FB83.00 Premenopausal idiopathic osteopenia –– FB83.01 Postmenopausal osteopenia –– FB83.02 Senile osteopenia –– FB83.03 Osteopenia of disuse –– FB83.04 Drug-induced osteopenia –– FB83.0Y Other specified osteopenia –– FB83.0Z Osteopenia, unspecified –– FB83.10 Premenopausal idiopathic osteoporosis –– FB83.11 Postmenopausal osteoporosis –– FB83.12 Osteoporosis of disuse –– FB83.13 Drug-induced osteoporosis –– FB83.14 Osteoporosis due to malabsorption –– FB83.1Y Other specified osteoporosis –– FB83.1Z Osteoporosis, unspecified –– FB83.20 Aluminium bone disease –– FB83.21 Adult osteomalacia due to malnutrition –– FB83.22 Drug-induced adult osteomalacia –– FB83.2Y Other specified adult osteomalacia –– FB83.2Z Adult osteomalacia, unspecified FB84 Osteomyelitis or osteitis – FB84.0 Acute haematogenous osteomyelitis – FB84.1 Other acute osteomyelitis – FB84.2 Subacute osteomyelitis – FB84.3 Chronic multifocal osteomyelitis – FB84.4 Chronic osteomyelitis with draining sinus – FB84.5 Other chronic haematogenous osteomyelitis – FB84.Y Other specified osteomyelitis or osteitis – FB84.Z Osteomyelitis or osteitis, unspecified FB85 Paget disease of bone – FB85.0 Juvenile Paget disease – FB85.1 Paget disease of bone in neoplastic disease – FB85.Y Other specified Paget disease of bone – FB85.Z Paget disease of bone, unspecified FB86 Disorders associated with bone growth – FB86.0 Epiphyseal arrest – FB86.1 Bone hyperplasias – FB86.2 Osteolysis – FB86.Y Other specified disorders associated with bone growth – FB86.Z Disorders associated with bone growth, unspecified –– FB86.10 Hypertrophic osteoarthropathy –– FB86.11 Hypertrophy of bone –– FB86.1Y Other specified bone hyperplasias –– FB86.1Z Bone hyperplasias, unspecified FB8Y Other specified osteopathies or chondropathies FB8Z Osteopathies or chondropathies, unspecified FC00 Certain specified acquired deformities of musculoskeletal system or connective tissue, not elsewhere classified FC00.0 Acquired deformity of nose FC00.1 Acquired deformity of neck FC00.2 Acquired deformity of chest or rib FC00.3 Acquired deformity of pelvis FC00.4 Acquired deformity of trunk FC00.Y Acquired deformities of musculoskeletal system and connective tissue, not classified elsewhere, other specified sites FC01 Postprocedural disorders of the musculoskeletal system FC01.0 Pseudarthrosis after fusion or arthrodesis FC01.1 Postlaminectomy syndrome, not elsewhere classified FC01.2 Post radiation kyphosis FC01.3 Postlaminectomy kyphosis FC01.4 Postsurgical lordosis FC01.5 Post radiation scoliosis FC01.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate FC01.7 Nonunion after arthrodesis FC01.8 Postsurgical osteolysis FC01.9 Postoophorectomy osteoporosis FC01.A Postsurgical malabsorption osteoporosis – FC01.70 Nonunion after spinal arthrodesis – FC01.7Y Nonunion after arthrodesis of other sites FC0Y Other specified diseases of the musculoskeletal system or connective tissue FC0Z Diseases of the musculoskeletal system or connective tissue, unspecified – GB40 Nephritic syndrome – GB41 Nephrotic syndrome – GB42 Persistent proteinuria or albuminuria –– GB42.0 Albuminuria, Grade A2 –– GB42.1 Albuminuria, Grade A3 –– GB42.Y Other specified persistent proteinuria or albuminuria –– GB42.Z Persistent proteinuria or albuminuria, unspecified – GB4Y Other specified glomerular diseases – GB4Z Glomerular diseases, unspecified – GB50 Acute tubulo-interstitial nephritis – GB51 Acute pyelonephritis – GB52 Acute tubular necrosis – GB53 Acute renal papillary necrosis – GB54 Tubulo-interstitial nephritis, not specified as acute or chronic – GB55 Chronic tubulo-interstitial nephritis –– GB55.0 Balkan nephropathy –– GB55.1 Nephropathy induced by heavy metals –– GB55.2 Chronic urate nephropathy –– GB55.Y Other specified chronic tubulo-interstitial nephritis –– GB55.Z Chronic tubulo-interstitial nephritis, unspecified – GB56 Obstructive or reflux nephropathy –– GB56.0 Hydronephrosis with ureteropelvic junction obstruction –– GB56.1 Hydronephrosis with ureteral obstruction –– GB56.2 Hydronephrosis with ureteral orifice obstruction –– GB56.3 Hydronephrosis due to bladder obstruction –– GB56.4 Other or unspecified hydronephrosis –– GB56.5 Hydronephrosis and reflux nephropathy with vesicoureteral or vesico-uretero-renal reflux –– GB56.Y Other specified obstructive or reflux nephropathy –– GB56.Z Obstructive or reflux nephropathy, unspecified – GB57 Nephrocalcinosis – GB58 Pyonephrosis – GB59 Renal or perinephric abscess – GB5Y Other specified renal tubulo-interstitial diseases – GB5Z Renal tubulo-interstitial diseases, unspecified – GB60 Acute kidney failure –– GB60.0 Acute kidney failure, stage 1 –– GB60.1 Acute kidney failure, stage 2 –– GB60.2 Acute kidney failure, stage 3 –– GB60.Y Other specified acute kidney failure –– GB60.Z Acute kidney failure, stage unspecified – GB61 Chronic kidney disease –– GB61.0 Chronic kidney disease, stage 1 –– GB61.1 Chronic kidney disease, stage 2 –– GB61.2 Chronic kidney disease, stage 3a –– GB61.3 Chronic kidney disease, stage 3b –– GB61.4 Chronic kidney disease, stage 4 –– GB61.5 Chronic kidney disease, stage 5 –– GB61.Z Chronic kidney disease, stage unspecified – GB6Z Kidney failure, unspecified – GB70 Calculus of upper urinary tract –– GB70.0 Calculus of kidney –– GB70.1 Calculus of ureter –– GB70.Z Calculus of upper urinary tract, unspecified ––– GB70.00 Staghorn calculus ––– GB70.0Y Other specified calculus of kidney ––– GB70.0Z Calculus of kidney, unspecified – GB71 Calculus of lower urinary tract –– GB71.0 Calculus in bladder –– GB71.1 Calculus in urethra –– GB71.2 Calculus of bowel segments for urinary diversion –– GB71.Z Calculus of lower urinary tract, unspecified – GB7Z Urolithiasis, unspecified – GB80 Nonfamilial nongenetic cystic kidney disease –– GB80.0 Simple renal cyst –– GB80.1 Complex renal cyst –– GB80.2 Subscapular or perirenal urinoma –– GB80.Y Other specified nonfamilial nongenetic cystic kidney disease –– GB80.Z Nonfamilial nongenetic cystic kidney disease, unspecified – GB81 Autosomal dominant polycystic kidney disease – GB82 Autosomal dominant tubulointerstitial disease – GB83 Nephronophthisis – GB8Y Other specified cystic or dysplastic kidney disease – GB8Z Cystic or dysplastic kidney disease, unspecified GB90 Certain specified disorders of kidney or ureter – GB90.0 Nephroptosis – GB90.1 Hydroureter – GB90.2 Ureteral kinking or deviation without obstruction – GB90.3 Ischaemia or infarction of kidney – GB90.4 Renal tubular function disorders – GB90.Y Other specified disorders of kidney or ureter –– GB90.40 Hypotonia-cystinuria type 1 –– GB90.41 Pseudohypoaldosteronism type 1 –– GB90.42 Fanconi syndrome –– GB90.43 Bartter syndrome –– GB90.44 Renal tubular acidosis –– GB90.45 Renal glycosuria –– GB90.46 Tubular disorders of sodium or potassium transport –– GB90.47 Aminoaciduria –– GB90.48 Disorders of calcium or phosphate excretion –– GB90.49 Renal hypocalciuria –– GB90.4A Nephrogenic diabetes insipidus –– GB90.4Y Other specified renal tubular function disorders –– GB90.4Z Renal tubular function disorders, unspecified – GC00 Cystitis –– GC00.0 Trigonitis –– GC00.1 Infectious cystitis –– GC00.2 Contracted urinary bladder –– GC00.3 Interstitial cystitis –– GC00.Y Other specified cystitis –– GC00.Z Cystitis, unspecified – GC01 Other disorders of bladder –– GC01.0 Bladder neck obstruction –– GC01.1 Vesical fistula, not elsewhere classified –– GC01.2 Diverticulum of bladder –– GC01.3 Rupture of bladder, nontraumatic –– GC01.4 Neuromuscular dysfunction of bladder, not elsewhere classified –– GC01.Y Other specified disorders of bladder –– GC01.Z Disorder of bladder, unspecified – GC02 Urethritis and urethral syndrome –– GC02.0 Urethral abscess –– GC02.1 Nonspecific urethritis –– GC02.Y Other specified urethritis and urethral syndrome –– GC02.Z Urethritis and urethral syndrome, unspecified – GC03 Urethral stricture – GC04 Fistula of the genitourinary tract –– GC04.0 Urethral fistula –– GC04.1 Fistulae involving female genital tract –– GC04.2 Ureteral fistula –– GC04.Y Other specified fistula of the genitourinary tract –– GC04.Z Fistula of the genitourinary tract, unspecified ––– GC04.10 Vesicovaginal fistula ––– GC04.11 Fistula of small intestine to vagina ––– GC04.12 Fistula of large intestine to vagina ––– GC04.13 Female genital tract-skin fistulae ––– GC04.14 Urethrovaginal fistula ––– GC04.15 Combined urethrovesicovaginal fistula ––– GC04.16 Rectovaginal fistula ––– GC04.17 Vesicouterine fistula with severe scar or extensive tissue loss ––– GC04.18 Other combined urinary fistula with severe scar or extensive tissue loss ––– GC04.19 Combined urinary and rectal fistula including cloaca with severe scar or extensive tissue loss ––– GC04.1A Vaginal stenosis or gynatresia related to obstetric fistula ––– GC04.1Y Other specified fistulae involving female genital tract ––– GC04.1Z Fistulae involving female genital tract, unspecified – GC05 Prolapsed urethral mucosa – GC06 Urethral diverticulum – GC07 Urethral caruncle – GC08 Urinary tract infection, site not specified –– GC08.0 Urinary tract infection, site not specified, due to Escherichia coli –– GC08.1 Urinary tract infection, site not specified, due to Klebsiella pneumoniae –– GC08.2 Urinary tract infection, site not specified, due to Proteus –– GC08.Y Urinary tract infection, site not specified due to other agent –– GC08.Z Urinary tract infection, site and agent not specified – GC0Y Other diseases of urinary system GC2Z Diseases of the urinary system, unspecified – JB44.6 Puerperal osteomalacia ––– MA18.00 Abnormal glucose tolerance test
synonyms Other specified maternal diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com